JP2020132590A - Polymerizable resin composition for dental use - Google Patents
Polymerizable resin composition for dental use Download PDFInfo
- Publication number
- JP2020132590A JP2020132590A JP2019029921A JP2019029921A JP2020132590A JP 2020132590 A JP2020132590 A JP 2020132590A JP 2019029921 A JP2019029921 A JP 2019029921A JP 2019029921 A JP2019029921 A JP 2019029921A JP 2020132590 A JP2020132590 A JP 2020132590A
- Authority
- JP
- Japan
- Prior art keywords
- group
- resin composition
- meth
- dental
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011342 resin composition Substances 0.000 title claims abstract description 71
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 82
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims abstract description 59
- 239000000203 mixture Substances 0.000 claims abstract description 52
- 239000000463 material Substances 0.000 claims abstract description 40
- 229920000642 polymer Polymers 0.000 claims abstract description 32
- 238000000576 coating method Methods 0.000 claims abstract description 17
- 239000011248 coating agent Substances 0.000 claims abstract description 16
- 150000001450 anions Chemical class 0.000 claims abstract description 11
- 238000011049 filling Methods 0.000 claims abstract description 11
- -1 acryloyloxy Chemical group 0.000 claims description 98
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate group Chemical group C(C=C)(=O)[O-] NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 55
- 125000000217 alkyl group Chemical group 0.000 claims description 54
- 150000001875 compounds Chemical class 0.000 claims description 49
- 239000004851 dental resin Substances 0.000 claims description 43
- 125000004432 carbon atom Chemical group C* 0.000 claims description 40
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical group NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 35
- 239000005548 dental material Substances 0.000 claims description 21
- 125000000524 functional group Chemical group 0.000 claims description 13
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 12
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 claims description 12
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical group C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 claims description 9
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical group C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 claims description 9
- 150000002500 ions Chemical class 0.000 claims description 9
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical group COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 claims description 9
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 9
- 150000001768 cations Chemical class 0.000 claims description 8
- 239000003999 initiator Substances 0.000 claims description 8
- 125000002947 alkylene group Chemical group 0.000 claims description 7
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- RUACIFFMSHZUKZ-UHFFFAOYSA-O 3-Acrylamidopropyl trimethylammonium Chemical compound C[N+](C)(C)CCCNC(=O)C=C RUACIFFMSHZUKZ-UHFFFAOYSA-O 0.000 claims description 5
- 230000000379 polymerizing effect Effects 0.000 claims description 5
- 239000003479 dental cement Substances 0.000 claims description 4
- STXPHWZNSHDIHJ-UHFFFAOYSA-O benzyl-dimethyl-[3-(prop-2-enoylamino)propyl]azanium Chemical compound C=CC(=O)NCCC[N+](C)(C)CC1=CC=CC=C1 STXPHWZNSHDIHJ-UHFFFAOYSA-O 0.000 claims description 3
- 239000011350 dental composite resin Substances 0.000 claims description 3
- YIOJGTBNHQAVBO-UHFFFAOYSA-N dimethyl-bis(prop-2-enyl)azanium Chemical compound C=CC[N+](C)(C)CC=C YIOJGTBNHQAVBO-UHFFFAOYSA-N 0.000 claims description 3
- AIUAMYPYEUQVEM-UHFFFAOYSA-N trimethyl(2-prop-2-enoyloxyethyl)azanium Chemical compound C[N+](C)(C)CCOC(=O)C=C AIUAMYPYEUQVEM-UHFFFAOYSA-N 0.000 claims description 3
- 239000000470 constituent Substances 0.000 claims description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N p-toluenesulfonic acid Substances CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N thiocyanic acid Chemical compound SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims 2
- ODRZUUBZEIXMOS-UHFFFAOYSA-N benzyl-ethyl-dimethylazanium Chemical compound CC[N+](C)(C)CC1=CC=CC=C1 ODRZUUBZEIXMOS-UHFFFAOYSA-N 0.000 claims 1
- 238000003860 storage Methods 0.000 abstract description 12
- 229910052736 halogen Inorganic materials 0.000 abstract description 6
- 150000002367 halogens Chemical class 0.000 abstract description 3
- 125000004103 aminoalkyl group Chemical group 0.000 description 25
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 23
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 22
- 125000005429 oxyalkyl group Chemical group 0.000 description 20
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 17
- 230000003373 anti-fouling effect Effects 0.000 description 17
- 239000000853 adhesive Substances 0.000 description 16
- 230000001070 adhesive effect Effects 0.000 description 16
- 239000010408 film Substances 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 239000000178 monomer Substances 0.000 description 13
- 238000006116 polymerization reaction Methods 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 11
- WGQKYBSKWIADBV-UHFFFAOYSA-O benzylaminium Chemical compound [NH3+]CC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-O 0.000 description 11
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 11
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 11
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 239000003960 organic solvent Substances 0.000 description 10
- 210000004268 dentin Anatomy 0.000 description 8
- 239000000945 filler Substances 0.000 description 8
- INQDDHNZXOAFFD-UHFFFAOYSA-N 2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOCCOC(=O)C=C INQDDHNZXOAFFD-UHFFFAOYSA-N 0.000 description 7
- 210000003298 dental enamel Anatomy 0.000 description 7
- 238000002845 discoloration Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 6
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000005977 Ethylene Substances 0.000 description 6
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 238000001723 curing Methods 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000000976 ink Substances 0.000 description 6
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 6
- 239000011976 maleic acid Substances 0.000 description 6
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 125000006165 cyclic alkyl group Chemical group 0.000 description 5
- 125000004122 cyclic group Chemical group 0.000 description 5
- 239000001530 fumaric acid Substances 0.000 description 5
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 5
- 239000007943 implant Substances 0.000 description 5
- 239000011256 inorganic filler Substances 0.000 description 5
- 229910003475 inorganic filler Inorganic materials 0.000 description 5
- 239000012766 organic filler Substances 0.000 description 5
- 238000000016 photochemical curing Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- VNQXSTWCDUXYEZ-UHFFFAOYSA-N 1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione Chemical compound C1CC2(C)C(=O)C(=O)C1C2(C)C VNQXSTWCDUXYEZ-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 4
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate group Chemical group C(C(=C)C)(=O)[O-] CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 4
- 239000010445 mica Substances 0.000 description 4
- 229910052618 mica group Inorganic materials 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000012719 thermal polymerization Methods 0.000 description 4
- JWYVGKFDLWWQJX-UHFFFAOYSA-N 1-ethenylazepan-2-one Chemical compound C=CN1CCCCCC1=O JWYVGKFDLWWQJX-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 3
- 230000001588 bifunctional effect Effects 0.000 description 3
- 229930006711 bornane-2,3-dione Natural products 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical group CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 3
- UUORTJUPDJJXST-UHFFFAOYSA-N n-(2-hydroxyethyl)prop-2-enamide Chemical compound OCCNC(=O)C=C UUORTJUPDJJXST-UHFFFAOYSA-N 0.000 description 3
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical group C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- PSGCQDPCAWOCSH-UHFFFAOYSA-N (4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl) prop-2-enoate Chemical compound C1CC2(C)C(OC(=O)C=C)CC1C2(C)C PSGCQDPCAWOCSH-UHFFFAOYSA-N 0.000 description 2
- AXTADRUCVAUCRS-UHFFFAOYSA-N 1-(2-hydroxyethyl)pyrrole-2,5-dione Chemical compound OCCN1C(=O)C=CC1=O AXTADRUCVAUCRS-UHFFFAOYSA-N 0.000 description 2
- XLPJNCYCZORXHG-UHFFFAOYSA-N 1-morpholin-4-ylprop-2-en-1-one Chemical compound C=CC(=O)N1CCOCC1 XLPJNCYCZORXHG-UHFFFAOYSA-N 0.000 description 2
- VUIWJRYTWUGOOF-UHFFFAOYSA-N 2-ethenoxyethanol Chemical compound OCCOC=C VUIWJRYTWUGOOF-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- NDWUBGAGUCISDV-UHFFFAOYSA-N 4-hydroxybutyl prop-2-enoate Chemical compound OCCCCOC(=O)C=C NDWUBGAGUCISDV-UHFFFAOYSA-N 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 241000193755 Bacillus cereus Species 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 101000720524 Gordonia sp. (strain TY-5) Acetone monooxygenase (methyl acetate-forming) Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- DAKWPKUUDNSNPN-UHFFFAOYSA-N Trimethylolpropane triacrylate Chemical compound C=CC(=O)OCC(CC)(COC(=O)C=C)COC(=O)C=C DAKWPKUUDNSNPN-UHFFFAOYSA-N 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- MPIAGWXWVAHQBB-UHFFFAOYSA-N [3-prop-2-enoyloxy-2-[[3-prop-2-enoyloxy-2,2-bis(prop-2-enoyloxymethyl)propoxy]methyl]-2-(prop-2-enoyloxymethyl)propyl] prop-2-enoate Chemical compound C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C MPIAGWXWVAHQBB-UHFFFAOYSA-N 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- CQLNQGQDXMGDBC-UHFFFAOYSA-N benzyl-dimethyl-(2-prop-2-enoyloxyethyl)azanium Chemical compound C=CC(=O)OCC[N+](C)(C)CC1=CC=CC=C1 CQLNQGQDXMGDBC-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 229910052570 clay Inorganic materials 0.000 description 2
- 150000001923 cyclic compounds Chemical class 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- VFHVQBAGLAREND-UHFFFAOYSA-N diphenylphosphoryl-(2,4,6-trimethylphenyl)methanone Chemical compound CC1=CC(C)=CC(C)=C1C(=O)P(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 VFHVQBAGLAREND-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 2
- 125000003827 glycol group Chemical group 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- PQXKHYXIUOZZFA-UHFFFAOYSA-M lithium fluoride Chemical compound [Li+].[F-] PQXKHYXIUOZZFA-UHFFFAOYSA-M 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- OMNKZBIFPJNNIO-UHFFFAOYSA-N n-(2-methyl-4-oxopentan-2-yl)prop-2-enamide Chemical compound CC(=O)CC(C)(C)NC(=O)C=C OMNKZBIFPJNNIO-UHFFFAOYSA-N 0.000 description 2
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 2
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 229920001483 poly(ethyl methacrylate) polymer Polymers 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 239000007870 radical polymerization initiator Substances 0.000 description 2
- 238000010526 radical polymerization reaction Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- VZTGWJFIMGVKSN-UHFFFAOYSA-O trimethyl-[3-(2-methylprop-2-enoylamino)propyl]azanium Chemical compound CC(=C)C(=O)NCCC[N+](C)(C)C VZTGWJFIMGVKSN-UHFFFAOYSA-O 0.000 description 2
- GNWBLLYJQXKPIP-ZOGIJGBBSA-N (1s,3as,3bs,5ar,9ar,9bs,11as)-n,n-diethyl-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1h-indeno[5,4-f]quinoline-1-carboxamide Chemical compound CN([C@@H]1CC2)C(=O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)N(CC)CC)[C@@]2(C)CC1 GNWBLLYJQXKPIP-ZOGIJGBBSA-N 0.000 description 1
- LAIJAUHBAWLPCO-UHFFFAOYSA-N (4-tert-butylcyclohexyl) prop-2-enoate Chemical compound CC(C)(C)C1CCC(OC(=O)C=C)CC1 LAIJAUHBAWLPCO-UHFFFAOYSA-N 0.000 description 1
- HUDYANRNMZDQGA-UHFFFAOYSA-N 1-[4-(dimethylamino)phenyl]ethanone Chemical compound CN(C)C1=CC=C(C(C)=O)C=C1 HUDYANRNMZDQGA-UHFFFAOYSA-N 0.000 description 1
- KCWWCWMGJOWTMY-UHFFFAOYSA-N 1-benzyl-5-phenyl-1,3-diazinane-2,4,6-trione Chemical compound O=C1C(C=2C=CC=CC=2)C(=O)NC(=O)N1CC1=CC=CC=C1 KCWWCWMGJOWTMY-UHFFFAOYSA-N 0.000 description 1
- OBNIRVVPHSLTEP-UHFFFAOYSA-N 1-ethoxy-2-(2-hydroxyethoxy)ethanol;prop-2-enoic acid Chemical compound OC(=O)C=C.CCOC(O)COCCO OBNIRVVPHSLTEP-UHFFFAOYSA-N 0.000 description 1
- 239000012956 1-hydroxycyclohexylphenyl-ketone Substances 0.000 description 1
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 description 1
- BTJPUDCSZVCXFQ-UHFFFAOYSA-N 2,4-diethylthioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC(CC)=CC(CC)=C3SC2=C1 BTJPUDCSZVCXFQ-UHFFFAOYSA-N 0.000 description 1
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
- DPBJAVGHACCNRL-UHFFFAOYSA-N 2-(dimethylamino)ethyl prop-2-enoate Chemical compound CN(C)CCOC(=O)C=C DPBJAVGHACCNRL-UHFFFAOYSA-N 0.000 description 1
- PTXMNGZGHGYOIJ-UHFFFAOYSA-N 2-[4-hydroxy-3,3-bis(hydroxymethyl)butan-2-yl]oxyethyl prop-2-enoate Chemical compound OCC(CO)(CO)C(C)OCCOC(=O)C=C PTXMNGZGHGYOIJ-UHFFFAOYSA-N 0.000 description 1
- GVNHOISKXMSMPX-UHFFFAOYSA-N 2-[butyl(2-hydroxyethyl)amino]ethanol Chemical compound CCCCN(CCO)CCO GVNHOISKXMSMPX-UHFFFAOYSA-N 0.000 description 1
- JUVSRZCUMWZBFK-UHFFFAOYSA-N 2-[n-(2-hydroxyethyl)-4-methylanilino]ethanol Chemical compound CC1=CC=C(N(CCO)CCO)C=C1 JUVSRZCUMWZBFK-UHFFFAOYSA-N 0.000 description 1
- OJPDDQSCZGTACX-UHFFFAOYSA-N 2-[n-(2-hydroxyethyl)anilino]ethanol Chemical compound OCCN(CCO)C1=CC=CC=C1 OJPDDQSCZGTACX-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- PFMHXSKWMSCZAH-UHFFFAOYSA-N 3-aminopropyl-benzyl-dimethylazanium Chemical compound NCCC[N+](C)(C)CC1=CC=CC=C1 PFMHXSKWMSCZAH-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- CHHCCYVOJBBCIY-UHFFFAOYSA-N 3-chloro-n,n-dimethylaniline Chemical compound CN(C)C1=CC=CC(Cl)=C1 CHHCCYVOJBBCIY-UHFFFAOYSA-N 0.000 description 1
- NIAXWFTYAJQENP-UHFFFAOYSA-N 3-ethenyl-2h-1,3-oxazole Chemical compound C=CN1COC=C1 NIAXWFTYAJQENP-UHFFFAOYSA-N 0.000 description 1
- UVRCNEIYXSRHNT-UHFFFAOYSA-N 3-ethylpent-2-enamide Chemical compound CCC(CC)=CC(N)=O UVRCNEIYXSRHNT-UHFFFAOYSA-N 0.000 description 1
- NMGBFVPQUCLJGM-UHFFFAOYSA-N 3-ethylphthalic acid Chemical compound CCC1=CC=CC(C(O)=O)=C1C(O)=O NMGBFVPQUCLJGM-UHFFFAOYSA-N 0.000 description 1
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 1
- OFNISBHGPNMTMS-UHFFFAOYSA-N 3-methylideneoxolane-2,5-dione Chemical compound C=C1CC(=O)OC1=O OFNISBHGPNMTMS-UHFFFAOYSA-N 0.000 description 1
- ZLPORNPZJNRGCO-UHFFFAOYSA-N 3-methylpyrrole-2,5-dione Chemical compound CC1=CC(=O)NC1=O ZLPORNPZJNRGCO-UHFFFAOYSA-N 0.000 description 1
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 1
- YDIYEOMDOWUDTJ-UHFFFAOYSA-N 4-(dimethylamino)benzoic acid Chemical compound CN(C)C1=CC=C(C(O)=O)C=C1 YDIYEOMDOWUDTJ-UHFFFAOYSA-N 0.000 description 1
- XYZWMVYYUIMRIZ-UHFFFAOYSA-N 4-bromo-n,n-dimethylaniline Chemical compound CN(C)C1=CC=C(Br)C=C1 XYZWMVYYUIMRIZ-UHFFFAOYSA-N 0.000 description 1
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 1
- ZWAPMFBHEQZLGK-UHFFFAOYSA-N 5-(dimethylamino)-2-methylidenepentanamide Chemical compound CN(C)CCCC(=C)C(N)=O ZWAPMFBHEQZLGK-UHFFFAOYSA-N 0.000 description 1
- HTKIZIQFMHVTRJ-UHFFFAOYSA-N 5-butyl-1,3-diazinane-2,4,6-trione Chemical compound CCCCC1C(=O)NC(=O)NC1=O HTKIZIQFMHVTRJ-UHFFFAOYSA-N 0.000 description 1
- YYVYAPXYZVYDHN-UHFFFAOYSA-N 9,10-phenanthroquinone Chemical compound C1=CC=C2C(=O)C(=O)C3=CC=CC=C3C2=C1 YYVYAPXYZVYDHN-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241001248697 Alaudidae Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- AKENDDKWVRAQPW-UHFFFAOYSA-N C(C)C(C(=O)O)CC(=O)O.C(C=C)(=O)O Chemical compound C(C)C(C(=O)O)CC(=O)O.C(C=C)(=O)O AKENDDKWVRAQPW-UHFFFAOYSA-N 0.000 description 1
- MPOHYWOIFCUXAR-UHFFFAOYSA-N C(C)C1(C(=O)O)C(C(=O)O)CCCC1.C(C=C)(=O)O Chemical compound C(C)C1(C(=O)O)C(C(=O)O)CCCC1.C(C=C)(=O)O MPOHYWOIFCUXAR-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 208000032767 Device breakage Diseases 0.000 description 1
- 206010064687 Device related infection Diseases 0.000 description 1
- OJIYIVCMRYCWSE-UHFFFAOYSA-M Domiphen bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1 OJIYIVCMRYCWSE-UHFFFAOYSA-M 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Natural products OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- AKNUHUCEWALCOI-UHFFFAOYSA-N N-ethyldiethanolamine Chemical compound OCCN(CC)CCO AKNUHUCEWALCOI-UHFFFAOYSA-N 0.000 description 1
- 229930192627 Naphthoquinone Natural products 0.000 description 1
- 229920000459 Nitrile rubber Polymers 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-L Oxalate Chemical compound [O-]C(=O)C([O-])=O MUBZPKHOEPUJKR-UHFFFAOYSA-L 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- LFOXEOLGJPJZAA-UHFFFAOYSA-N [(2,6-dimethoxybenzoyl)-(2,4,4-trimethylpentyl)phosphoryl]-(2,6-dimethoxyphenyl)methanone Chemical compound COC1=CC=CC(OC)=C1C(=O)P(=O)(CC(C)CC(C)(C)C)C(=O)C1=C(OC)C=CC=C1OC LFOXEOLGJPJZAA-UHFFFAOYSA-N 0.000 description 1
- ORLQHILJRHBSAY-UHFFFAOYSA-N [1-(hydroxymethyl)cyclohexyl]methanol Chemical compound OCC1(CO)CCCCC1 ORLQHILJRHBSAY-UHFFFAOYSA-N 0.000 description 1
- RUDUCNPHDIMQCY-UHFFFAOYSA-N [3-(2-sulfanylacetyl)oxy-2,2-bis[(2-sulfanylacetyl)oxymethyl]propyl] 2-sulfanylacetate Chemical compound SCC(=O)OCC(COC(=O)CS)(COC(=O)CS)COC(=O)CS RUDUCNPHDIMQCY-UHFFFAOYSA-N 0.000 description 1
- VEBCLRKUSAGCDF-UHFFFAOYSA-N ac1mi23b Chemical compound C1C2C3C(COC(=O)C=C)CCC3C1C(COC(=O)C=C)C2 VEBCLRKUSAGCDF-UHFFFAOYSA-N 0.000 description 1
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 150000007656 barbituric acids Chemical class 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- ILWNQJSSTDJSJX-UHFFFAOYSA-N benzyl-dimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium Chemical compound CC(=C)C(=O)OCC[N+](C)(C)CC1=CC=CC=C1 ILWNQJSSTDJSJX-UHFFFAOYSA-N 0.000 description 1
- YBWHZRJWKIKBOL-UHFFFAOYSA-O benzyl-dimethyl-[3-(2-methylprop-2-enoylamino)propyl]azanium Chemical compound CC(=C)C(=O)NCCC[N+](C)(C)CC1=CC=CC=C1 YBWHZRJWKIKBOL-UHFFFAOYSA-O 0.000 description 1
- GRHHVGHRQARKAM-UHFFFAOYSA-N benzyl-dimethyl-propylazanium Chemical compound CCC[N+](C)(C)CC1=CC=CC=C1 GRHHVGHRQARKAM-UHFFFAOYSA-N 0.000 description 1
- MQDJYUACMFCOFT-UHFFFAOYSA-N bis[2-(1-hydroxycyclohexyl)phenyl]methanone Chemical compound C=1C=CC=C(C(=O)C=2C(=CC=CC=2)C2(O)CCCCC2)C=1C1(O)CCCCC1 MQDJYUACMFCOFT-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 239000012986 chain transfer agent Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000000805 composite resin Substances 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- NAPSCFZYZVSQHF-UHFFFAOYSA-N dimantine Chemical compound CCCCCCCCCCCCCCCCCCN(C)C NAPSCFZYZVSQHF-UHFFFAOYSA-N 0.000 description 1
- 229950010007 dimantine Drugs 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical compound CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 description 1
- 229960001859 domiphen bromide Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000010556 emulsion polymerization method Methods 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- BNKAXGCRDYRABM-UHFFFAOYSA-N ethenyl dihydrogen phosphate Chemical class OP(O)(=O)OC=C BNKAXGCRDYRABM-UHFFFAOYSA-N 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- UCBGQODNBRKZGB-UHFFFAOYSA-N ethyl carbamate;prop-2-enamide Chemical compound NC(=O)C=C.NC(=O)C=C.CCOC(N)=O UCBGQODNBRKZGB-UHFFFAOYSA-N 0.000 description 1
- JZMPIUODFXBXSC-UHFFFAOYSA-N ethyl carbamate;prop-2-enoic acid Chemical compound OC(=O)C=C.OC(=O)C=C.CCOC(N)=O JZMPIUODFXBXSC-UHFFFAOYSA-N 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 229940091249 fluoride supplement Drugs 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- BJEPYKJPYRNKOW-UWTATZPHSA-M malate ion Chemical compound [O-]C(=O)[C@H](O)CC(O)=O BJEPYKJPYRNKOW-UWTATZPHSA-M 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000002905 metal composite material Substances 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N methanesulfonic acid Substances CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- DBQGARDMYOMOOS-UHFFFAOYSA-N methyl 4-(dimethylamino)benzoate Chemical compound COC(=O)C1=CC=C(N(C)C)C=C1 DBQGARDMYOMOOS-UHFFFAOYSA-N 0.000 description 1
- CRVGTESFCCXCTH-UHFFFAOYSA-N methyl diethanolamine Chemical compound OCCN(C)CCO CRVGTESFCCXCTH-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- NBFRQCOZERNGEX-UHFFFAOYSA-N n,n,3,5-tetramethylaniline Chemical group CN(C)C1=CC(C)=CC(C)=C1 NBFRQCOZERNGEX-UHFFFAOYSA-N 0.000 description 1
- CWOMTHDOJCARBY-UHFFFAOYSA-N n,n,3-trimethylaniline Chemical compound CN(C)C1=CC=CC(C)=C1 CWOMTHDOJCARBY-UHFFFAOYSA-N 0.000 description 1
- GYVGXEWAOAAJEU-UHFFFAOYSA-N n,n,4-trimethylaniline Chemical compound CN(C)C1=CC=C(C)C=C1 GYVGXEWAOAAJEU-UHFFFAOYSA-N 0.000 description 1
- MXHTZQSKTCCMFG-UHFFFAOYSA-N n,n-dibenzyl-1-phenylmethanamine Chemical compound C=1C=CC=CC=1CN(CC=1C=CC=CC=1)CC1=CC=CC=C1 MXHTZQSKTCCMFG-UHFFFAOYSA-N 0.000 description 1
- ISGXOWLMGOPVPB-UHFFFAOYSA-N n,n-dibenzylaniline Chemical compound C=1C=CC=CC=1CN(C=1C=CC=CC=1)CC1=CC=CC=C1 ISGXOWLMGOPVPB-UHFFFAOYSA-N 0.000 description 1
- FZPXKEPZZOEPGX-UHFFFAOYSA-N n,n-dibutylaniline Chemical compound CCCCN(CCCC)C1=CC=CC=C1 FZPXKEPZZOEPGX-UHFFFAOYSA-N 0.000 description 1
- AJUXDFHPVZQOGF-UHFFFAOYSA-N n,n-dimethyl-1-naphthylamine Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1 AJUXDFHPVZQOGF-UHFFFAOYSA-N 0.000 description 1
- YWFWDNVOPHGWMX-UHFFFAOYSA-N n,n-dimethyldodecan-1-amine Chemical compound CCCCCCCCCCCCN(C)C YWFWDNVOPHGWMX-UHFFFAOYSA-N 0.000 description 1
- QMHNQZGXPNCMCO-UHFFFAOYSA-N n,n-dimethylhexan-1-amine Chemical compound CCCCCCN(C)C QMHNQZGXPNCMCO-UHFFFAOYSA-N 0.000 description 1
- IKZPRXHVTFNIEK-UHFFFAOYSA-N n,n-dimethylnaphthalen-2-amine Chemical compound C1=CC=CC2=CC(N(C)C)=CC=C21 IKZPRXHVTFNIEK-UHFFFAOYSA-N 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- OTLDLKLSNZMTTA-UHFFFAOYSA-N octahydro-1h-4,7-methanoindene-1,5-diyldimethanol Chemical compound C1C2C3C(CO)CCC3C1C(CO)C2 OTLDLKLSNZMTTA-UHFFFAOYSA-N 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- SIWVEOZUMHYXCS-UHFFFAOYSA-N oxo(oxoyttriooxy)yttrium Chemical compound O=[Y]O[Y]=O SIWVEOZUMHYXCS-UHFFFAOYSA-N 0.000 description 1
- LXTZRIBXKVRLOA-UHFFFAOYSA-N padimate a Chemical compound CCCCCOC(=O)C1=CC=C(N(C)C)C=C1 LXTZRIBXKVRLOA-UHFFFAOYSA-N 0.000 description 1
- FZUGPQWGEGAKET-UHFFFAOYSA-N parbenate Chemical compound CCOC(=O)C1=CC=C(N(C)C)C=C1 FZUGPQWGEGAKET-UHFFFAOYSA-N 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- POZPGRADIOPGIR-UHFFFAOYSA-N phenanthrene-1,4-dione Chemical compound C1=CC2=CC=CC=C2C2=C1C(=O)C=CC2=O POZPGRADIOPGIR-UHFFFAOYSA-N 0.000 description 1
- NKGGYWQZHFAHRK-UHFFFAOYSA-N phenanthrene-3,4-dione Chemical compound C1=CC=CC2=C(C(C(=O)C=C3)=O)C3=CC=C21 NKGGYWQZHFAHRK-UHFFFAOYSA-N 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000007406 plaque accumulation Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- POSICDHOUBKJKP-UHFFFAOYSA-N prop-2-enoxybenzene Chemical compound C=CCOC1=CC=CC=C1 POSICDHOUBKJKP-UHFFFAOYSA-N 0.000 description 1
- FZYDVDRIQZXXIW-UHFFFAOYSA-N propanoic acid;prop-2-enoic acid Chemical compound CCC(O)=O.OC(=O)C=C FZYDVDRIQZXXIW-UHFFFAOYSA-N 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010558 suspension polymerization method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- USFMMZYROHDWPJ-UHFFFAOYSA-N trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium Chemical compound CC(=C)C(=O)OCC[N+](C)(C)C USFMMZYROHDWPJ-UHFFFAOYSA-N 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- NLVXSWCKKBEXTG-UHFFFAOYSA-N vinylsulfonic acid Chemical class OS(=O)(=O)C=C NLVXSWCKKBEXTG-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 229940105963 yttrium fluoride Drugs 0.000 description 1
- RBORBHYCVONNJH-UHFFFAOYSA-K yttrium(iii) fluoride Chemical compound F[Y](F)F RBORBHYCVONNJH-UHFFFAOYSA-K 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Dental Preparations (AREA)
Abstract
Description
本発明は、熱及び光などの活性エネルギー線に対して重合性を有する歯科用樹脂組成物及び該樹脂組成物を重合してなる歯科用材料、器具等に関する。 The present invention relates to a dental resin composition having polymerizability with respect to active energy rays such as heat and light, and dental materials, instruments and the like obtained by polymerizing the resin composition.
歯科用材料は主に高分子材料、セラミックス材料、金属材料及びこれらを組み合わせた複合材料に分類され、虫歯の治療、自歯を白く美しく見せるための審美治療や義歯、インプラント治療など異なる目的に合わせて使用されている。これらの材料は咬合に耐える程度の強度が求められると同時に、長期間に渡って安全性、抗菌性、防汚性、接着耐久性、耐変色性、インプラントに使用される合金の耐食性なども要求されている。 Dental materials are mainly classified into polymer materials, ceramic materials, metal materials and composite materials that combine these, and are suitable for different purposes such as dental caries treatment, aesthetic treatment to make your teeth look white and beautiful, dentures, and implant treatment. Is used. These materials are required to be strong enough to withstand occlusion, and at the same time, they are also required to have long-term safety, antibacterial properties, antifouling properties, adhesive durability, discoloration resistance, and corrosion resistance of alloys used for implants. Has been done.
しかし、口腔内の常在菌が多く、歯や義歯の表面でプラークを形成し、詰め物や冠などで治療した箇所が再度虫歯になりやすい問題や、長年使用していた入れ歯の内面、義歯床の粘膜面、インプラント周辺に歯周病原性菌の付着、活性化による細菌感染が起こりやすいという問題があった。 However, there are many indigenous bacteria in the oral cavity, plaque is formed on the surface of teeth and dentures, and the part treated with stuffing or crown tends to become cavities again, and the inner surface of dentures and denture base that have been used for many years There was a problem that periodontal pathogenic bacteria adhered to the mucosal surface and around the implant, and bacterial infection was likely to occur due to activation.
口腔内微生物、細菌を抑制するために、臭化ドミフェン、クロルヘキシジン、トリクロサン、第四級アンモニウム塩などの抗菌作用を有する化合物を配合した口腔リンス液、歯磨き粉、ジェルなどが開発されてきたが、抗菌作用を維持することができず、また詰め物や冠、義歯床とインプラント周辺に届くことが困難であり、さらにハロゲン系製品が多く、刺激性が強く、長期間使用による人体への安全性を懸念する問題があった。 Oral rinse solutions, toothpastes, gels, etc. containing compounds with antibacterial activity such as domiphen bromide, chlorhexidine, triclosan, and quaternary ammonium salts have been developed to suppress oral microorganisms and bacteria. It cannot maintain its action, it is difficult to reach the filling, crown, denture base and implant area, and there are many halogen-based products, it is highly irritating, and there is concern about safety to the human body due to long-term use. There was a problem to do.
また、歯科治療に用いる充填材や表面被覆材などのレジン中に抗菌性金属イオン源として銀イオンを担持させたゼオライトの粒子を配合する方法(特許文献1)、有効量の抗菌性脂質成分と硬化性成分を含有する硬化性抗菌性歯科用組成物(特許文献2)、リン酸残基を有する重合性化合物を配合することにより硬化後抗菌性成分が固定化される光硬化型レジン(特許文献3)、第四級アンモニウム塩に重合性基を導入した抗菌性モノマー(12-?methacryloyloxydodecylpyridinium bromide (MDPB))を配合した歯科用接着剤(非特許文献1)が提案された。しかし、銀イオンも脂質成分も経時的に溶出するという本質的な問題があり、また、リン酸残基やMDPBのアニオンであるブロモイオンが食物飲料の酸や口腔内細菌が出す酸により置換されたり、溶出されたりする場合もあり、決して人体に対する安全性が確保できているとは言えず、永久抗菌性を有していることとも言えず、さらに、これらのリン酸やブロモイオンによるインプラントのフィックスチャー(金属部分)が腐食され、インプラントの破折問題が懸念されている。 Further, a method of blending zeolite particles in which silver ions are carried as an antibacterial metal ion source in a resin such as a filler or a surface coating material used for dental treatment (Patent Document 1), and an effective amount of antibacterial lipid component A curable antibacterial dental composition containing a curable component (Patent Document 2) and a photocurable resin in which the antibacterial component is immobilized after curing by blending a polymerizable compound having a phosphate residue (Patent). Document 3) and a dental adhesive (Non-Patent Document 1) containing an antibacterial monomer (12-? Methadryloyloxydodecylpyridinium bromide (MDPB)) in which a polymerizable group is introduced into a quaternary ammonium salt have been proposed. However, there is an essential problem that both silver ions and lipid components are eluted over time, and phosphate residues and bromo ions, which are anions of MDPB, are replaced by acids in food drinks and acids produced by oral bacteria. In some cases, it may be eluted, and it cannot be said that the safety to the human body is ensured, it cannot be said that it has permanent antibacterial properties, and further, the implants made of these phosphoric acid and bromo ions Fixtures (metal parts) are corroded, and there is concern about the problem of implant breakage.
さらに、歯や義歯の表面、周りに付着するプラークは口腔細菌の温床であり、食物残渣、細菌の粘着或いは付着によるプラーク蓄積を防止する必要があった。ところが、前記いずれの先行技術文献においても歯科用材料として重要な防汚性について、言及されなかった。 Furthermore, the plaque adhering to the surface and surroundings of teeth and dentures is a hotbed of oral bacteria, and it is necessary to prevent plaque accumulation due to food residue, adhesion or adhesion of bacteria. However, none of the prior art documents mentioned above mentions the antifouling property, which is important as a dental material.
本発明は、抗菌性、防汚性、耐変色性を有し、安全性が高く、熱及び光などの活性エネルギー線に対して優れる重合性を有する歯科用樹脂組成物を提供することを課題とする。また、本発明は、前記組成物を熱或いは光により単独又は他の重合性化合物と共重合してなる重合物を含有する、半永久的抗菌性、防汚性を有する高安全性の歯科用材料を提供することを課題とする。さらに、本発明は、前記組成物及び/又は前記重合物を配合して得られる歯科用のコンポジットレジン、歯冠材、接着剤、充填材料、義歯用材料、義歯床用材料及び前記組成物及び/又は前記重合物を含有する立体造形物用抗菌性材料、防汚性材料による表面被覆された医療器具、抗菌性と防汚性を有する立体造形物を提供することを課題とする。 An object of the present invention is to provide a dental resin composition having antibacterial property, antifouling property, discoloration resistance, high safety, and excellent polymerization property with respect to active energy rays such as heat and light. And. Further, the present invention is a highly safe dental material having semi-permanent antibacterial and antifouling properties, which contains a polymer obtained by copolymerizing the composition alone or with another polymerizable compound by heat or light. The challenge is to provide. Further, the present invention relates to a dental composite resin, a crown material, an adhesive, a filling material, a denture material, a denture base material and the composition obtained by blending the composition and / or the polymer. / Or, it is an object of the present invention to provide an antibacterial material for a three-dimensional model containing the polymer, a medical device whose surface is coated with an antifouling material, and a three-dimensional model having antibacterial and antifouling properties.
本発明者らは、前記課題を解決するために鋭意研究を重ねた結果、不飽和基を有する第四級アンモニウム塩(A)及び/又はその単独又は他の重合性化合物と共重合してなる重合物(オリゴマー、ポリマーとも称する)を必須成分として含有することにより長期の安全性、抗菌性、防汚性と耐変色性を有する歯科用樹脂組成物、歯科用レジン、充填材、接着剤などの歯科用材料、立体造形物用抗菌性樹・防汚性インク、抗菌性と防汚性樹脂に被覆された医療機器、抗菌性と防汚性を有する立体造形物などを見出し、本発明に至ったものである。 As a result of diligent research to solve the above problems, the present inventors have obtained a quaternary ammonium salt (A) having an unsaturated group and / or copolymerization thereof alone or with other polymerizable compounds. Dental resin compositions, dental resins, fillers, adhesives, etc. that have long-term safety, antibacterial properties, antifouling properties and discoloration resistance by containing a polymer (also called oligomer or polymer) as an essential component. Dental materials, antibacterial trees and antifouling inks for three-dimensional shaped objects, medical devices coated with antibacterial and antifouling resin, three-dimensional shaped objects with antibacterial and antifouling properties, etc. It has arrived.
すなわち、本発明は
(1)一般式(1)に示される不飽和基を有する第四級アンモニウム塩(A)を含有する重合性歯科用樹脂組成物、
(2)不飽和基を有する第四級アンモニウム塩(A)は、不飽和基として(メタ)アクリレート基、(メタ)アクリルアミド基、ビニル基、ビニルエーテル基、メチルビニルエーテル基、アリル基、(メタ)アリルエーテル基とマレイミド基からなる群より選択される1種以上の不飽和結合を有する官能基であることを特徴とする前記(1)に記載の重合性歯科用樹脂組成物、
(3)不飽和基を有する第四級アンモニウム塩(A)は、カチオンとして(メタ)アクリロイルアミノプロピルトリメチルアンモニウム、(メタ)アクリロイルアミノプロピルジメチルベンジルアンモニウム、(メタ)アクリロイルオキシエチルトリメチルアンモニウム、(メタ)アクリロイルオキシエチルジメチルベンジルアンモニウム、ジアリルジメチルアンモニウムからなる群より選択される1種以上のカチオンであることを特徴とする前記(1)又は(2)に記載の重合性歯科用樹脂組成物、
(4)不飽和基を有する第四級アンモニウム塩(A)は、アニオンとしてp−トルエンスルホン酸イオン、テトラフルオロホウ酸イオン、ヘキサフルオロリン酸イオン、トリフルオロメタンスルホン酸イオン、テトラフェニルホウ酸イオン、チオシアン酸イオン、ビス(フルオロスルホニル)イミドアニオン、ビス(トリフルオロメタンスルホニル)イミドアニオンとサッカリン酸イオンからなる群より選択される1種以上のアニオンであることを特徴とする前記(1)〜(3)のいずれか一項に記載の重合性歯科用樹脂組成物、
(5)不飽和基を有する第四級アンモニウム塩(A)を構成単位として0.1質量%以上含有することを特徴とする前記(1)〜(4)のいずれか一項に記載の重合性歯科用樹脂組成物、
(6)前記(1)〜(5)のいずれか一項に記載の重合性樹脂組成物を重合してなる重合物を含有することを特徴とする歯科用樹脂組成物、
(7)エチレン性不飽和基を有する化合物(B)((A)を除く)を5〜99質量%含有することを特徴とする前記(1)〜(6)のいずれか一項に記載の歯科用樹脂組成物、
(8)エチレン性不飽和基を有する化合物(B)は、不飽和基として(メタ)アクリレート基、(メタ)アクリルアミド基、ビニル基、ビニルエーテル基、メチルビニルエーテル基、アリル基、(メタ)アリルエーテル基とマレイミド基からなる群より選択される1種以上の化合物であることを特徴とする前記(7)に記載の歯科用樹脂組成物、
(9)更に光重合開始剤(C)を0.1〜10質量%含有することを特徴とする前記(1)〜(5)と前記(7)、(8)のいずれか一項に記載の光硬化型歯科用樹脂組成物、
(10)前記(1)〜(5)と前記(7)〜(9)のいずれか一項に記載の重合性樹脂組成物を重合してなる重合物を含有することを特徴とする歯科用樹脂組成物、
(11)前記(1)〜(5)と前記(7)〜(9)のいずれか一項に記載の重合性歯科用樹脂組成物を含有する歯科用コンポジットレジン、
(12)前記(1)〜(5)と前記(7)〜(9)のいずれか一項に記載の重合性樹脂組成物を含有するする立体造形物用抗菌性インク、
(13)前記(1)〜(10)のいずれか一項に記載の樹脂組成物を用いてなる歯科用材料、
(14)前記(1)〜(10)のいずれか一項に記載の樹脂組成物を用いてなる歯冠材、
(15)前記(1)〜(10)のいずれか一項に記載の樹脂組成物を用いてなる歯科用接着剤、
(16)前記(1)〜(10)のいずれか一項に記載の樹脂組成物を用いてなる歯科用表面被覆材、
(17)前記(1)〜(10)のいずれか一項に記載の樹脂組成物を用いてなる歯科用充填材料、
(18)前記(1)〜(10)のいずれか一項に記載の樹脂組成物を用いてなる歯科用義歯材料、
(19)前記(1)〜(10)のいずれか一項に記載の樹脂組成物を用いてなる義歯床用材料、
(20)前記(1)〜(10)のいずれか一項に記載の樹脂組成物による表面被覆された医療器具、
(21)前記(12)に記載のインクを用いて形成される抗菌性立体造形物
を提供するものである。
That is, the present invention comprises (1) a polymerizable dental resin composition containing a quaternary ammonium salt (A) having an unsaturated group represented by the general formula (1).
(2) The quaternary ammonium salt (A) having an unsaturated group has a (meth) acrylate group, a (meth) acrylamide group, a vinyl group, a vinyl ether group, a methyl vinyl ether group, an allyl group, and (meth) as unsaturated groups. The polymerizable dental resin composition according to (1) above, which is a functional group having one or more unsaturated bonds selected from the group consisting of an allyl ether group and a maleimide group.
(3) The quaternary ammonium salt (A) having an unsaturated group has (meth) acryloylaminopropyltrimethylammonium, (meth) acryloylaminopropyldimethylbenzylammonium, (meth) acryloyloxyethyltrimethylammonium, and (meth) as cations. ) The polymerizable dental resin composition according to (1) or (2) above, which is one or more cations selected from the group consisting of acryloyloxyethyl dimethylbenzylammonium and diallyldimethylammonium.
(4) The quaternary ammonium salt (A) having an unsaturated group has p-toluene sulfonate ion, tetrafluoroborate ion, hexafluorophosphate ion, trifluoromethanesulfonate ion, and tetraphenylborate ion as anions. , Thiosic acid ion, bis (fluorosulfonyl) imide anion, bis (trifluoromethanesulfonyl) imide anion and one or more anions selected from the group consisting of saccharic acid ion. The polymerizable dental resin composition according to any one of 3).
(5) The polymerization according to any one of (1) to (4) above, wherein the quaternary ammonium salt (A) having an unsaturated group is contained in an amount of 0.1% by mass or more as a constituent unit. Sex dental resin composition,
(6) A dental resin composition, which comprises a polymer obtained by polymerizing the polymerizable resin composition according to any one of (1) to (5) above.
(7) The item according to any one of (1) to (6) above, wherein the compound (B) having an ethylenically unsaturated group (excluding (A)) is contained in an amount of 5 to 99% by mass. Dental resin composition,
(8) The compound (B) having an ethylenically unsaturated group has a (meth) acrylate group, a (meth) acrylamide group, a vinyl group, a vinyl ether group, a methyl vinyl ether group, an allyl group, and a (meth) allyl ether as unsaturated groups. The dental resin composition according to (7) above, which is one or more compounds selected from the group consisting of a group and a maleimide group.
(9) The above-mentioned (1) to (5) and any one of the above (7) and (8), which further contain 0.1 to 10% by mass of the photopolymerization initiator (C). Photocurable dental resin composition,
(10) For dentistry, which contains a polymer obtained by polymerizing the polymerizable resin composition according to any one of (1) to (5) and (7) to (9). Resin composition,
(11) A dental composite resin containing the polymerizable dental resin composition according to any one of (1) to (5) and (7) to (9).
(12) An antibacterial ink for a three-dimensional model containing the polymerizable resin composition according to any one of (1) to (5) and (7) to (9).
(13) A dental material using the resin composition according to any one of (1) to (10) above.
(14) A crown material using the resin composition according to any one of (1) to (10) above.
(15) A dental adhesive using the resin composition according to any one of (1) to (10) above.
(16) A dental surface coating material using the resin composition according to any one of (1) to (10) above.
(17) A dental filling material using the resin composition according to any one of (1) to (10) above.
(18) A dental denture material using the resin composition according to any one of (1) to (10) above.
(19) A material for a denture base using the resin composition according to any one of (1) to (10) above.
(20) A medical device whose surface is coated with the resin composition according to any one of (1) to (10) above.
(21) Provided is an antibacterial three-dimensional model formed by using the ink according to (12) above.
本発明によれば、不飽和基を有する第四級アンモニウム塩(A)及び/又はその単独或いは他の重合性化合物と共重合してなる重合物(オリゴマー、ポリマー)を含有することにより、抗菌性、防汚性、耐変色性に優れ、熱的重合性、光硬化性、他の重合性化合物との共重合性がよく、高安全性及び保存安定性を有する重合性樹脂組成物を取得することができ、また、これらの重合性樹脂組成物を熱及び/又は光などの活性エネルギー線照射による熱重合、光硬化又は熱・光併用のハイブリッド型やデュアル型硬化により、抗菌効果、防汚効果を半永久的に持続することができ、かつ、良好な耐変色性、強度、硬度と表面平滑性、耐傷性、耐久性(耐加水分解性と耐磨耗性)を有する各種歯科用材料、立体造形物及びこれらに被覆された医療用器具を取得することができる。 According to the present invention, it is antibacterial by containing a quaternary ammonium salt (A) having an unsaturated group and / or a polymer (oligomer, polymer) obtained by copolymerizing with the quaternary ammonium salt (A) alone or with another polymerizable compound. Obtained a polymerizable resin composition having excellent properties, stain resistance, discoloration resistance, thermal polymerizable property, photocurability, good copolymerizability with other polymerizable compounds, high safety and storage stability. In addition, these polymerizable resin compositions can be subjected to antibacterial effect and prevention by thermal polymerization by irradiation with active energy rays such as heat and / or light, photocuring, or hybrid type or dual type curing using both heat and light. Various dental materials that can sustain the stain effect semi-permanently and have good discoloration resistance, strength, hardness and surface smoothness, scratch resistance, and durability (hydrolysis resistance and abrasion resistance). , Three-dimensional shaped objects and medical instruments covered with them can be obtained.
以下に、本発明を詳細に説明する。
本発明に用いられる不飽和基を有する第四級アンモニウム塩(A)は、一般式(1)で表わされる化合物である(式中、R1、R2とR3は互いに同一であっても異なっていてもよく、各々独立に炭素数1〜36の直鎖状又は分岐鎖状のアルキル基や水酸基或いはアミン基に置換されたアルキル基、炭素数1〜36の直鎖状又は分岐鎖状のアルケニル基や水酸基或いはアミン基に置換されたアルケニル基、或いはベンジル基を表し、Lは不飽和結合を表し、Yは炭素数1〜36のアルキレン基を表し、Q-は非ハロゲン系アニオンを表す。)。具体的には、不飽和基を有するアンモニウムカチオンと、その対イオンである非ハロゲン系アニオンから構成される第四級アンモニウム塩である。
The quaternary ammonium salt (A) having an unsaturated group used in the present invention is a compound represented by the general formula (1) (in the formula, even if R 1 , R 2 and R 3 are the same as each other). They may be different, each independently having a linear or branched alkyl group having 1 to 36 carbon atoms, an alkyl group substituted with a hydroxyl group or an amine group, or a linear or branched alkyl group having 1 to 36 carbon atoms. alkenyl group or a hydroxyl group or an alkenyl group substituted amine group, or a benzyl group, L represents a unsaturated bond, Y represents an alkylene group having 1 to 36 carbon atoms, Q - is a non-halogen anion Represent.). Specifically, it is a quaternary ammonium salt composed of an ammonium cation having an unsaturated group and a non-halogen anion which is a counter ion thereof.
本発明に用いられる不飽和基を有する第四級アンモニウム塩(A)及び/又はそのオリゴマー、ポリマーは広範囲の抗菌スペクトルを示し、大腸菌、緑膿菌、ブドウ状球菌、MRSA、セレウス菌、白癬菌、肝炎桿菌、黒カビ、カンジタなど多種のバクテリアや細菌に対して優れる抗菌力を有する。その理由は明確ではないが、アンモニウム塩の親水性とN−置換アルキル基の疎水性とのバランス、アンモニウム塩の高い電子密度、及び不飽和結合を有する官能基の大きさなどの相互作用によるものと本発明者らは推測している。また、不飽和基を有する第四級アンモニウム塩(A)をモノマーとして配合しても、オリゴマー化やポリマー化してから配合しても、同等の抗菌性や防カビ性を示し、レジンタイプやフィラータイプ、光硬化型、熱重合・硬化型などの抗菌性材料として好適に用いられる。さらに、第四級アンモニウム塩は優れた細胞適合性と生体適合性を有するため、使用者の自歯、義歯や皮膚を刺激しないだけでなく、歯や皮膚に対する保護効果も認められ、歯科用材料や化粧品用材料としても好適に配合することができる。 The quaternary ammonium salt (A) having an unsaturated group and / or its oligomer and polymer used in the present invention show a wide range of antibacterial spectra, and Escherichia coli, Pseudomonas aeruginosa, staphylococcus, MRSA, Bacillus cereus, and Bacillus cereus , Hepatitis bacillus, black mold, candida, etc. It has excellent antibacterial activity against various bacteria and bacteria. The reason is not clear, but it is due to the interaction between the hydrophilicity of the ammonium salt and the hydrophobicity of the N-substituted alkyl group, the high electron density of the ammonium salt, and the size of the functional group having an unsaturated bond. The present inventors speculate. In addition, even if the quaternary ammonium salt (A) having an unsaturated group is blended as a monomer, or if it is blended after being oligomerized or polymerized, it exhibits the same antibacterial and antifungal properties, and is a resin type or filler. It is suitably used as an antibacterial material such as a type, a photocurable type, and a thermopolymerization / curing type. Furthermore, since the quaternary ammonium salt has excellent cell compatibility and biocompatibility, it not only does not irritate the user's own teeth, artificial teeth and skin, but also has a protective effect on the teeth and skin, and is a dental material. It can also be suitably blended as a material for cosmetics.
一般式(1)で表される不飽和基を有する第四級アンモニウム塩(A)のカチオンとして、具体的には、不飽和結合を有するアミノアルキル(Y)トリアルキル(R1)アンモニウム、不飽和結合を有するアミノアルキル(Y)トリアルキル(R2)アンモニウム、不飽和結合を有するアミノアルキル(Y)トリアルキル(R3)アンモニウム、不飽和結合を有するアミノアルキル(Y)アルキル(R1)ジアルキル(R2)アンモニウム、不飽和結合を有するアミノアルキル(Y)アルキル(R1)ジアルキル(R3)アンモニウム、不飽和結合を有するアミノアルキル(Y)アルキル(R2)ジアルキル(R1)アンモニウム、不飽和結合を有するアミノアルキル(Y)アルキル(R2)ジアルキル(R3)アンモニウム、不飽和結合を有するアミノアルキル(Y)アルキル(R3)ジアルキル(R1)アンモニウム、不飽和結合を有するアミノアルキル(Y)アルキル(R3)ジアルキル(R2)アンモニウム、不飽和結合を有するアミノアルキル(Y)アルキル(R1)アルキル(R2)アルキル(R3)アンモニウム、不飽和結合を有するアミノアルキル(Y)ジアルキル(R1)ベンジルアンモニウム、不飽和結合を有するアミノアルキル(Y)ジアルキル(R2)ベンジルアンモニウム、不飽和結合を有するアミノアルキル(Y)ジアルキル(R3)ベンジルアンモニウム、不飽和結合を有するアミノアルキル(Y)アルキル(R1)アルキル(R2)ベンジルアンモニウム、不飽和結合を有するアミノアルキル(Y)アルキル(R2)アルキル(R3)ベンジルアンモニウム、不飽和結合を有するアミノアルキル(Y)アルキル(R1)アルキル(R3)ベンジルアンモニウム、不飽和結合を有するアミノアルキル(Y)アルキル(R1)ジベンジルアンモニウム、不飽和結合を有するアミノアルキル(Y)アルキル(R2)ジベンジルアンモニウム、不飽和結合を有するアミノアルキル(Y)アルキル(R3)ジベンジルアンモニウム、不飽和結合を有するアミノアルキル(Y)トリベンジルアンモニウム、不飽和結合を有するオキシアルキル(Y)トリアルキル(R1)アンモニウム、不飽和結合を有するオキシアルキル(Y)トリアルキル(R2)アンモニウム、不飽和結合を有するオキシアルキル(Y)トリアルキル(R3)アンモニウム、不飽和結合を有するオキシアルキル(Y)アルキル(R1)ジアルキル(R2)アンモニウム、不飽和結合を有するオキシアルキル(Y)アルキル(R1)ジアルキル(R3)アンモニウム、不飽和結合を有するオキシアルキル(Y)アルキル(R2)ジアルキル(R1)アンモニウム、不飽和結合を有するオキシアルキル(Y)アルキル(R2)ジアルキル(R3)アンモニウム、不飽和結合を有するオキシアルキル(Y)アルキル(R3)ジアルキル(R1)アンモニウム、不飽和結合を有するオキシアルキル(Y)アルキル(R3)ジアルキル(R2)アンモニウム、不飽和結合を有するオキシアルキル(Y)アルキル(R1)アルキル(R2)アルキル(R3)アンモニウム、不飽和結合を有するオキシアルキル(Y)ジアルキル(R1)ベンジルアンモニウム、不飽和結合を有するオキシアルキル(Y)ジアルキル(R2)ベンジルアンモニウム、不飽和結合を有するオキシアルキル(Y)ジアルキル(R3)ベンジルアンモニウム、不飽和結合を有するオキシアルキル(Y)アルキル(R1)アルキル(R2)ベンジルアンモニウム、不飽和結合を有するオキシアルキル(Y)アルキル(R2)アルキル(R3)ベンジルアンモニウム、不飽和結合を有するオキシアルキル(Y)アルキル(R1)アルキル(R3)ベンジルアンモニウム、不飽和結合を有するオキシアルキル(Y)アルキル(R1)ジベンジルアンモニウム、不飽和結合を有するオキシアルキル(Y)アルキル(R2)ジベンジルアンモニウム、不飽和結合を有するオキシアルキル(Y)アルキル(R3)ジベンジルアンモニウム、不飽和結合を有するオキシアルキル(Y)トリベンジルアンモニウム等が挙げられる。また、これらの不飽和基を有する第四級アンモニウム塩(A)は1種類単独で使用してもよいし、また2種類以上併用してもよい。 As cations of the quaternary ammonium salt having an unsaturated group represented by the general formula (1) (A), specifically, aminoalkyl (Y) trialkyl (R 1) ammonium having an unsaturated bond, unsaturated Aminoalkyl (Y) trialkyl (R 2 ) ammonium with an unsaturated bond, aminoalkyl (Y) trialkyl (R 3 ) ammonium with an unsaturated bond, aminoalkyl (Y) alkyl (R 1 ) with an unsaturated bond Dialkyl (R 2 ) ammonium, aminoalkyl (Y) alkyl (R 1 ) dialkyl (R 3 ) ammonium with unsaturated bonds, aminoalkyl (Y) alkyl (R 2 ) dialkyl (R 1 ) ammonium with unsaturated bonds , Aminoalkyl (Y) alkyl (R 2 ) dialkyl (R 3 ) ammonium having an unsaturated bond, aminoalkyl (Y) alkyl (R 3 ) dialkyl (R 1 ) ammonium having an unsaturated bond, having an unsaturated bond Aminoalkyl (Y) alkyl (R 3 ) dialkyl (R 2 ) ammonium, aminoalkyl (Y) alkyl (R 1 ) alkyl (R 2 ) alkyl (R 3 ) ammonium with unsaturated bonds, amino with unsaturated bonds Alkyl (Y) dialkyl (R 1 ) benzylammonium, aminoalkyl (Y) dialkyl (R 2 ) benzylammonium with unsaturated bond, aminoalkyl (Y) dialkyl (R 3 ) benzylammonium with unsaturated bond, unsaturated Aminoalkyl (Y) alkyl (R 1 ) alkyl (R 2 ) benzylammonium with a bond, aminoalkyl (Y) alkyl (R 2 ) alkyl (R 3 ) benzylammonium with an unsaturated bond, amino with an unsaturated bond Alkyl (Y) alkyl (R 1 ) alkyl (R 3 ) benzylammonium, aminoalkyl (Y) alkyl (R 1 ) dibenzylammonium with unsaturated bonds, aminoalkyl (Y) alkyl (R 2 ) with unsaturated bonds ) dibenzyl ammonium, aminoalkyl (Y) alkyl (R 3) dibenzyl ammonium having an unsaturated bond, aminoalkyl (Y) tribenzyl ammonium having an unsaturated bond, oxyalkyl (Y) trialkyl having an unsaturated bond (R 1 ) ammonium, oxyalkyl (Y) trialkyl (R 2 ) ammoni with unsaturated bonds Um, oxyalkyl (Y) trialkyl (R 3 ) ammonium with unsaturated bonds, oxyalkyl (Y) alkyl (R 1 ) dialkyl (R 2 ) ammonium with unsaturated bonds, oxyalkyl with unsaturated bonds (R 2 ) Y) alkyl (R 1 ) dialkyl (R 3 ) ammonium, oxyalkyl (Y) alkyl (R 2 ) dialkyl (R 1 ) ammonium with unsaturated bonds, oxyalkyl (Y) alkyl (R 2 ) with unsaturated bonds ) Dialkyl (R 3 ) ammonium, oxyalkyl (Y) alkyl (R 3 ) dialkyl (R 1 ) ammonium with unsaturated bonds, oxyalkyl (Y) alkyl (R 3 ) dialkyl (R 2 ) with unsaturated bonds Ammonium, oxyalkyl (Y) alkyl (R 1 ) alkyl (R 2 ) alkyl (R 3 ) ammonium with unsaturated bonds, oxyalkyl (Y) dialkyl (R 1 ) benzyl ammonium with unsaturated bonds, unsaturated bonds Oxyalkyl (Y) dialkyl (R 2 ) benzylammonium having an unsaturated bond, oxyalkyl (Y) dialkyl (R 3 ) benzylammonium having an unsaturated bond, oxyalkyl (Y) alkyl (R 1 ) alkyl having an unsaturated bond (R 1 ) R 2 ) benzylammonium, oxyalkyl (Y) alkyl with unsaturated bond (R 2 ) alkyl (R 3 ) benzylammonium, oxyalkyl (Y) alkyl (R 1 ) alkyl (R 3 ) benzyl with unsaturated bond Ammonium, oxyalkyl (Y) alkyl (R 1 ) dibenzylammonium with unsaturated bond, oxyalkyl (Y) alkyl (R 2 ) dibenzylammonium with unsaturated bond, oxyalkyl (Y) with unsaturated bond Examples thereof include alkyl (R 3 ) dibenzylammonium and oxyalkyl (Y) tribenzylammonium having an unsaturated bond. Further, the quaternary ammonium salt (A) having these unsaturated groups may be used alone or in combination of two or more.
不飽和基を有する第四級アンモニウム塩(A)の不飽和基としては、メタクリレート基、アクリレート基、メタクリルアミド基、アクリルアミド基、ビニル基、ビニルエーテル基、メチルビニルエーテル基、アリル基、メタリルエーテル基、アリルエーテル基とマレイミド基からなる群より選択される1種以上の不飽和結合を有する官能基であって、これらの不飽和基を1種類有しても、2種類以上を有してもよい。 Examples of the unsaturated group of the quaternary ammonium salt (A) having an unsaturated group include a methacrylate group, an acrylate group, a methacrylicamide group, an acrylamide group, a vinyl group, a vinyl ether group, a methyl vinyl ether group, an allyl group and a metallicyl ether group. A functional group having one or more unsaturated bonds selected from the group consisting of an allyl ether group and a maleimide group, which may have one or more of these unsaturated groups. ..
不飽和基を有する第四級アンモニウム塩(A)中の不飽和基の個数は、1分子に当たり、前記各種不飽和基の数の合計(官能基数)が1〜10であることが好ましく、また、2〜6であることがより好ましい。官能基数が1未満であれば、非重合性化合物の存在により、光硬化型歯科用材料などに用いた場合、光硬化性、硬化物の硬度や強度が不十分となる問題がある。一方、官能基数が10を超えると、光硬化型コンポジットレジンに用いた場合、光硬化速度が著しく速くなって、重合熱の大量発生により火傷を負う恐れがある。 The number of unsaturated groups in the quaternary ammonium salt (A) having an unsaturated group is preferably 1 to 10 in total (the number of functional groups) of the various unsaturated groups per molecule. , 2 to 6, more preferably. If the number of functional groups is less than 1, there is a problem that the photocurability and the hardness and strength of the cured product are insufficient when used as a photocurable dental material due to the presence of the non-polymerizable compound. On the other hand, if the number of functional groups exceeds 10, when used in a photocurable composite resin, the photocuring rate becomes extremely high, and a large amount of heat of polymerization may cause burns.
不飽和基を有する第四級アンモニウム塩(A)のアニオン(Q-)としては、非ハロゲンイオンであれば、特に限定することはない。例えば、メタンスルホン酸イオン、ベンゼンスルホン酸イオン、p−トルエンスルホン酸イオン、テトラフルオロホウ酸イオン、ヘキサフルオロリン酸イオン、トリフルオロメタンスルホン酸イオン、テトラフェニルホウ酸イオン、チオシアン酸イオン、ビス(フルオロスルホニル)イミドアニオン、ビス(トリフルオロメタンスルホニル)イミドアニオン、ビス(ペンタフルオロエタンスルホニル)イミドアニオン、ノナフルオロブタンスルホン酸イオン、直鎖状のスルホンイミドアニオン、環状のイミドアニオン、ギ酸イオン、酢酸イオン、プロピオン酸イオン、シュウ酸イオン、コハク酸イオンなどカルボン酸イオン、グリコール酸イオン、乳酸イオン、ヒドロキシアクリル酸イオン、オキシ酪酸イオン、グリセリン酸イオン、リンゴ酸イオン、酒石酸イオン、クエン酸イオンなどのヒドロキシカルボン酸イオン、サリチル酸イオン、安息香酸イオンなど芳香族カルボン酸イオン、サッカリン酸イオン、アクリル酸イオン、メタクリル酸イオンなどの不飽和酸イオンから選ばれる少なくとも1種以上のイオンである。 Anion of the quaternary ammonium salt having an unsaturated group (A) (Q -) as, if non-halogen ion, not be particularly limited. For example, methanesulfonic acid ion, benzenesulfonic acid ion, p-toluenesulfonic acid ion, tetrafluoroborate ion, hexafluorophosphate ion, trifluoromethanesulfonic acid ion, tetraphenylborate ion, thiocyanate ion, bis (fluoro). Sulfonyl) imide anion, bis (trifluoromethanesulfonyl) imide anion, bis (pentafluoroethanesulfonyl) imide anion, nonafluorobutane sulfonic acid ion, linear sulfonimide anion, cyclic imide anion, formate ion, acetate ion, Hydrocarboxylic acids such as propionate ion, oxalate ion, succinate ion, glycolic acid ion, lactate ion, hydroxyacrylic acid ion, oxybutyrate ion, glycerate ion, malate ion, tartrate ion, citrate ion, etc. It is at least one or more ions selected from aromatic carboxylic acid ions such as acid ion, salicylate ion, and benzoate ion, and unsaturated acid ions such as saccharic acid ion, acrylic acid ion, and methacrylate ion.
本発明に用いられる不飽和基を有する第四級アンモニウム塩(A)は、前記のカチオンの中から1種又は2種以上のイオンを任意に選択し、さらに前記のアニオンの中から1種又は2種以上のイオンを任意に選択し、カチオンとアニオンを組み合わせることで構成されるオニウム塩である。これらの不飽和基を有する第四級アンモニウム塩(A)は単独で使用されてもよいし、また2種類以上併用してもよい。 For the quaternary ammonium salt (A) having an unsaturated group used in the present invention, one or more ions are arbitrarily selected from the above cations, and one or more of the above anions are further selected. It is an onium salt composed by arbitrarily selecting two or more types of ions and combining cations and anions. The quaternary ammonium salt (A) having these unsaturated groups may be used alone or in combination of two or more.
また、抗菌性に優れる点及び工業原料を入手しやすい点から、不飽和基を有する第四級アンモニウム塩(A)を構成するカチオンとして、アクリロイルアミノプロピルトリメチルアンモニウム、メタクリロイルアミノプロピルトリメチルアンモニウム、アクリロイルアミノプロピルジメチルベンジルアンモニウム、メタクリロイルアミノプロピルジメチルベンジルアンモニウム、アクリロイルオキシエチルトリメチルアンモニウム、メタクリロイルオキシエチルトリメチルアンモニウム、アクリロイルオキシエチルジメチルベンジルアンモニウム、メタクリロイルオキシエチルジメチルベンジルアンモニウム、ジアリルジメチルアンモニウムが好ましい。さらに、口腔内に長期間に使用される観点から、耐加水分解性、耐久性に優れるアクリルアミド系とメタクリルアミド系のアクリロイルアミノプロピルトリメチルアンモニウム、メタクリロイルアミノプロピルトリメチルアンモニウム、アクリロイルアミノプロピルジメチルベンジルアンモニウム、メタクリロイルアミノプロピルジメチルベンジルアンモニウムがより好ましい。 In addition, as cations constituting the quaternary ammonium salt (A) having an unsaturated group, acryloylaminopropyltrimethylammonium, methacryloylaminopropyltrimethylammonium, and acryloylamino are used because of their excellent antibacterial properties and easy availability of industrial raw materials. Preferables are propyldimethylbenzylammonium, methacryloylaminopropyldimethylbenzylammonium, acryloyloxyethyltrimethylammonium, methacryloyloxyethyltrimethylammonium, acryloyloxyethyldimethylbenzylammonium, methacryloyloxyethyldimethylbenzylammonium, and diallyldimethylammonium. Furthermore, from the viewpoint of long-term use in the oral cavity, acrylamide-based and methacrylamide-based acryloylaminopropyltrimethylammonium, methacryloylaminopropyltrimethylammonium, acryloylaminopropyldimethylbenzylammonium, and methacryloyl, which are excellent in hydrolysis resistance and durability. Aminopropyldimethylbenzylammonium is more preferred.
同様に、抗菌性に優れる点及び工業原料を入手しやすい点から、不飽和基を有する第四級アンモニウム塩(A)を構成するアニオンとして、p−トルエンスルホン酸イオン、テトラフルオロホウ酸イオン、ヘキサフルオロリン酸イオン、トリフルオロメタンスルホン酸イオン、テトラフェニルホウ酸イオン、チオシアン酸イオン、ビス(フルオロスルホニル)イミドアニオン、ビス(トリフルオロメタンスルホニル)イミドアニオン、サッカリン酸イオンが好ましい。さらに、防汚効果付与の観点から、有機フッ素系アニオンであるテトラフルオロホウ酸イオン、ヘキサフルオロリン酸イオン、トリフルオロメタンスルホン酸イオン、ビス(フルオロスルホニル)イミドアニオン、ビス(トリフルオロメタンスルホニル)イミドアニオンがより好ましい。 Similarly, p-toluenesulfonate ion, tetrafluoroborate ion, as anions constituting the quaternary ammonium salt (A) having an unsaturated group, from the viewpoint of excellent antibacterial properties and easy availability of industrial raw materials, Hexafluorophosphate ion, trifluoromethanesulfonic acid ion, tetraphenylborate ion, thiocyanate ion, bis (fluorosulfonyl) imide anion, bis (trifluoromethanesulfonyl) imide anion, and saccharate ion are preferable. Furthermore, from the viewpoint of imparting an antifouling effect, tetrafluoroborate ion, hexafluorophosphate ion, trifluoromethanesulfonic acid ion, bis (fluorosulfonyl) imide anion, and bis (trifluoromethanesulfonyl) imide anion, which are organic fluorine-based anions, are used. Is more preferable.
不飽和基を有する第四級アンモニウム塩(A)は高い抗菌効果を有するため、抗菌剤としてモノマーのまま樹脂組成物に配合することができる。また、熱重合や光重合(光硬化)により、ポリマーやオリゴマー化して、抗菌性の第四級アンモニウム塩構造を側鎖として有する半永久的高分子タイプ若しくはオリゴマータイプの抗菌剤として樹脂組成物に配合することができる。さらに、高分子タイプ抗菌剤、オリゴマータイプ抗菌剤として配合する場合、不飽和基を有する第四級アンモニウム塩(A)のブリードアウトを生じる可能性がなくなり、長期間に渡って安定的に抗菌性を付与することができる。 Since the quaternary ammonium salt (A) having an unsaturated group has a high antibacterial effect, it can be blended in the resin composition as a monomer as an antibacterial agent. In addition, it is polymerized or oligomerized by thermal polymerization or photopolymerization (photocuring) and blended into the resin composition as a semi-permanent polymer type or oligomer type antibacterial agent having an antibacterial quaternary ammonium salt structure as a side chain. can do. Furthermore, when blended as a polymer-type antibacterial agent or an oligomer-type antibacterial agent, there is no possibility of bleed-out of the quaternary ammonium salt (A) having an unsaturated group, and the antibacterial property is stable over a long period of time. Can be given.
不飽和基を有する第四級アンモニウム塩(A)の熱重合によるオリゴマー化とポリマー化は、単独重合又は汎用のビニル系化合物と共重合する方法が挙げられる。重合方法は、特に限定されるものではなく、公知のラジカル重合法により行うことができる。例えば、塊状重合法、有機溶媒中や水中の溶液重合法、懸濁重合法、乳化重合法などが挙げられる。有機溶媒中の溶液重合法を採用する場合、重合溶媒としては、トルエン、キシレン、酢酸エチル、酢酸ブチル、メチルエチルケトン、メチルアルコール、エチルアルコールなどを単独もしくは混合で用いることができる。また、重合開始剤としては、アゾ系、有機過酸化物系、無機過酸化物系、レドックス系など一般的に知られているラジカル重合開始剤が挙げられる。ラジカル重合開始剤の使用量としては、通常重合性成分総量に対して0.001〜10質量%程度である。さらに、連鎖移動剤による分子量の調整など通常のラジカル重合技術が適用される。 Examples of the oligomerization and polymerization of the quaternary ammonium salt (A) having an unsaturated group by thermal polymerization include homopolymerization or a method of copolymerizing with a general-purpose vinyl compound. The polymerization method is not particularly limited, and can be carried out by a known radical polymerization method. For example, a massive polymerization method, a solution polymerization method in an organic solvent or water, a suspension polymerization method, an emulsion polymerization method and the like can be mentioned. When the solution polymerization method in an organic solvent is adopted, toluene, xylene, ethyl acetate, butyl acetate, methyl ethyl ketone, methyl alcohol, ethyl alcohol and the like can be used alone or in combination as the polymerization solvent. In addition, examples of the polymerization initiator include generally known radical polymerization initiators such as azo-based, organic peroxide-based, inorganic peroxide-based, and redox-based. The amount of the radical polymerization initiator used is usually about 0.001 to 10% by mass with respect to the total amount of the polymerizable component. Further, ordinary radical polymerization techniques such as adjustment of molecular weight by a chain transfer agent are applied.
本発明に用いられる不飽和基を有する第四級アンモニウム塩(A)のオリゴマーとは、第四級アンモニウム塩(A)の構造がユニットとして1つ以上を含有し、且つ、200〜10,000未満の重量平均分子量を有する化合物である。 The oligomer of the quaternary ammonium salt (A) having an unsaturated group used in the present invention contains one or more units of the structure of the quaternary ammonium salt (A) and is 200 to 10,000. A compound having a weight average molecular weight of less than.
本発明に用いられる不飽和基を有する第四級アンモニウム塩(A)のポリマーとは、第四級アンモニウム塩(A)の構造がユニットとして1つ以上を含有し、且つ10,000以上の重量平均分子量を有する化合物である。 The polymer of the quaternary ammonium salt (A) having an unsaturated group used in the present invention contains one or more quaternary ammonium salt (A) structures as a unit and has a weight of 10,000 or more. It is a compound having an average molecular weight.
第四級アンモニウム塩(A)、そのオリゴマーとそのポリマーは、分子構造や分子量などによって、室温における状態(液体や固体)、粘度、水や汎用有機溶剤、汎用アクリルモノマーとアクリル樹脂などに対する溶解性、相溶性及び光硬化性が異なり、それらの使用方法、配合量などについて、特に限定することはなく、非光硬化型(熱重合)の歯科用材料としても、光硬化型歯科用材料としても、好適に用いることができ、抗菌性歯科用材料の要求物性に合わせて、第四級アンモニウム塩(A)、オリゴマーとポリマーから選ばれる1種または2種以上を組み合わせて使用することができる。 The quaternary ammonium salt (A), its oligomer and its polymer are soluble in the state at room temperature (liquid or solid), viscosity, water or general-purpose organic solvent, general-purpose acrylic monomer and acrylic resin, depending on the molecular structure and molecular weight. , Compatibility and photocurability are different, and their usage, blending amount, etc. are not particularly limited, and can be used as a non-photocurable (thermally polymerized) dental material or a photocurable dental material. , And can be preferably used, and one or a combination of two or more selected from a quaternary ammonium salt (A), an oligomer and a polymer can be used according to the required physical properties of the antibacterial dental material.
第四級アンモニウム塩(A)のオリゴマー又はポリマーを使用する場合、オリゴマー又はポリマー中の第四級アンモニウム塩(A)ユニットの含有量は0.1〜100質量%であり、好ましくは1〜95質量%である。含有量が0.1質量%未満の場合、歯科用材料に配合されるオリゴマーやポリマーの量にもよるが、十分な抗菌性が得られない可能性がある。含有量が1〜95質量%である場合、抗菌効果が十分に得られると共に、プライマー、フィラーなどの添加剤との相溶性を容易に調整することが可能であり、硬度、表面平滑性、自歯に対する接着性のよい歯科用材料を得ることができ、より好ましい。 When an oligomer or polymer of the quaternary ammonium salt (A) is used, the content of the quaternary ammonium salt (A) unit in the oligomer or polymer is 0.1 to 100% by mass, preferably 1 to 95%. It is mass%. If the content is less than 0.1% by mass, sufficient antibacterial properties may not be obtained, depending on the amount of oligomers and polymers blended in the dental material. When the content is 1 to 95% by mass, a sufficient antibacterial effect can be obtained, and compatibility with additives such as primers and fillers can be easily adjusted, resulting in hardness, surface smoothness, and self. A dental material having good adhesion to teeth can be obtained, which is more preferable.
本発明に用いられる第四級アンモニウム塩(A)のオリゴマー又はポリマーが室温において固体である場合、それらをフィラーとして歯科用樹脂組成物に組み込むことができる。また、有機溶媒中や液体の重合性化合物に溶解させ、得られた溶液を歯冠、義歯、医療器具や基材上に塗布した後、有機溶剤を蒸発させることにより、抗菌性コーティング、抗菌性歯冠、抗菌性義歯、抗菌性インク、抗菌性医療器具、抗菌性立体造形物が形成される。無溶剤系の場合、歯冠、義歯、医療器具や基材上に塗布したり、自歯の充填や補修したい部位に流し込み、その後熱又は光、或いは熱と光の併用により硬化させ、同様に抗菌性コーティング、抗菌性歯冠、抗菌性義歯、抗菌性インク、抗菌性医療器具、抗菌性立体造形物などを製作することができる。また、薄い歯科用表面被覆材として用いる場合、長期間に渡って十分な抗菌効果を維持するため、第四級アンモニウム塩(A)のオリゴマー又はポリマーを0.5質量%以上含有することが好ましく、1質量%以上含有することがより好ましい。一方、第四級アンモニウム塩(A)のオリゴマー又はポリマーを光硬化型歯科用レジンや立体造形用インクに組み込む場合、有機溶媒の一部又は全部がアクリルモノマー、オリゴマーなどの光硬化性成分により代替されることが可能である。その場合、得られるやや高粘度の塗布液を歯、義歯や器具の表面に塗布した後、有機溶剤を蒸発させ(有機溶剤が配合される場合)、光照射によりやや厚めの硬化塗膜、造形物(表面被覆材、歯冠材、立体造形で形成される義歯など)が形成される。この場合、十分な抗菌効果を付与するため、第四級アンモニウム塩(A)のオリゴマー又はポリマーを0.1質量%以上含有することが好ましく、0.5質量%以上含有することがより好ましい。 When the oligomer or polymer of the quaternary ammonium salt (A) used in the present invention is solid at room temperature, they can be incorporated into the dental resin composition as a filler. Further, antibacterial coating and antibacterial properties are obtained by dissolving the obtained solution in an organic solvent or in a liquid polymerizable compound, applying the obtained solution on a crown, a denture, a medical device or a base material, and then evaporating the organic solvent. Crowns, antibacterial dentures, antibacterial inks, antibacterial medical instruments, and antibacterial three-dimensional shaped objects are formed. In the case of solvent-free system, it is applied on crowns, dentures, medical instruments and base materials, poured into the part of the tooth to be filled or repaired, and then cured by heat or light, or a combination of heat and light, and similarly. It is possible to manufacture antibacterial coatings, antibacterial crowns, antibacterial dentures, antibacterial inks, antibacterial medical instruments, antibacterial three-dimensional shaped objects, and the like. When used as a thin dental surface coating material, it preferably contains 0.5% by mass or more of an oligomer or polymer of a quaternary ammonium salt (A) in order to maintain a sufficient antibacterial effect for a long period of time. It is more preferable to contain 1% by mass or more. On the other hand, when the oligomer or polymer of the quaternary ammonium salt (A) is incorporated into a photocurable dental resin or ink for three-dimensional modeling, part or all of the organic solvent is replaced by a photocurable component such as an acrylic monomer or an oligomer. It is possible to be done. In that case, after applying the obtained slightly high-viscosity coating liquid to the surface of teeth, dentures and instruments, the organic solvent is evaporated (when an organic solvent is mixed), and a slightly thicker cured coating film and modeling are performed by light irradiation. Objects (surface covering materials, crown materials, dentures formed by three-dimensional modeling, etc.) are formed. In this case, in order to impart a sufficient antibacterial effect, the oligomer or polymer of the quaternary ammonium salt (A) is preferably contained in an amount of 0.1% by mass or more, more preferably 0.5% by mass or more.
本発明に用いられる不飽和基を有する第四級アンモニウム塩(A)は、非光硬化型歯科用材料にも、光硬化型歯科用樹脂組成物にも組み込むことができる。また、ブリードアウトによる抗菌性の経時的低減を防止するため、光硬化型歯科材料に組み込むことが好ましい。光硬化型歯科用材料中の不飽和基を有する第四級アンモニウム塩(A)の含有量は0.1質量%以上であると抗菌性や防汚性が示され、また、持続的な抗菌性、防汚性を確保する観点から、0.5質量%以上を含有することが好ましい。 The quaternary ammonium salt (A) having an unsaturated group used in the present invention can be incorporated into both non-photocurable dental materials and photocurable dental resin compositions. Further, in order to prevent the antibacterial property from being reduced over time due to bleed-out, it is preferable to incorporate it into a photocurable dental material. When the content of the quaternary ammonium salt (A) having an unsaturated group in the photocurable dental material is 0.1% by mass or more, antibacterial and antifouling properties are shown, and continuous antibacterial activity is exhibited. From the viewpoint of ensuring properties and antifouling properties, it is preferably contained in an amount of 0.5% by mass or more.
本発明に用いられる不飽和基を有する第四級アンモニウム塩(A)、そのオリゴマー、そのポリマーは、それらからなる群より任意に選択される1種単独又は2種以上を併用することができる。歯科用材料中の第四級アンモニウム塩(A)のユニット含有量の合計が0.1質量%以上であれば、抗菌効果を付与することができる。また、0.5以上であれば、長期間に渡って安定且つ十分な抗菌効果が維持でき、より好ましい。 The quaternary ammonium salt (A) having an unsaturated group, its oligomer, and its polymer used in the present invention may be used alone or in combination of two or more, which are arbitrarily selected from the group consisting of them. When the total unit content of the quaternary ammonium salt (A) in the dental material is 0.1% by mass or more, the antibacterial effect can be imparted. Further, when it is 0.5 or more, a stable and sufficient antibacterial effect can be maintained for a long period of time, which is more preferable.
本発明の光硬化型抗菌性歯科用樹脂組成物は、エチレン性不飽和基を有する化合物(B)を含有することができる。エチレン性不飽和基を有する化合物(B)とは、不飽和基を有する第四級アンモニウム塩(A)を除いたエチレン性不飽和基を有する化合物であって、その含有量は特に限定されるものではないが、好適には、光硬化型樹脂組成物全体に対して5〜99質量%を含有することが好ましい。この範囲内であれば、十分な抗菌性を有するとともに、光硬化性、歯や医療器具の基材に対する密着性、接着性、得られる歯冠や義歯などの硬度、強度、耐変色性、耐久性などの特性をバランスよく調整することができる。 The photocurable antibacterial dental resin composition of the present invention can contain a compound (B) having an ethylenically unsaturated group. The compound (B) having an ethylenically unsaturated group is a compound having an ethylenically unsaturated group excluding the quaternary ammonium salt (A) having an unsaturated group, and its content is particularly limited. Although not, it is preferably contained in an amount of 5 to 99% by mass based on the entire photocurable resin composition. Within this range, it has sufficient antibacterial properties, photocurability, adhesion to the base material of teeth and medical instruments, adhesiveness, hardness, strength, discoloration resistance, durability of the obtained crown and denture. Characteristics such as sex can be adjusted in a well-balanced manner.
エチレン性不飽和基を有する化合物(B)の不飽和基は、(メタ)アクリレート基、(メタ)アクリルアミド基、ビニル基、ビニルエーテル基、メチルビニルエーテル基、アリル基、(メタ)アリルエーテル基とマレイミド基からなる群より選択される1種以上の不飽和結合を有する官能基である。また、エチレン性不飽和基を有する化合物(B)は、単官能のエチレン性不飽和基を有する化合物(単官能不飽和化合物)(b1)と2官能以上のエチレン性不飽和基を有する化合物(多官能不飽和化合物)(b2)から構成される。不飽和基を有する第四級アンモニウム塩(A)とそのオリゴマー及びそのポリマーの品種、構造、分子量などにより、エチレン性不飽和基を有する化合物(B)として(b1)或いは(b2)のみを用いても良いが、(b1)と(b2)を併用することにより、得られる硬化物(歯科用充填材料、義歯造形物など)の硬度と耐久性がより向上させることができる。 The unsaturated group of the compound (B) having an ethylenically unsaturated group is a (meth) acrylate group, a (meth) acrylamide group, a vinyl group, a vinyl ether group, a methyl vinyl ether group, an allyl group, a (meth) allyl ether group and a maleimide. A functional group having one or more unsaturated bonds selected from the group consisting of groups. The compound (B) having an ethylenically unsaturated group includes a compound having a monofunctional ethylenically unsaturated group (monofunctional unsaturated compound) (b1) and a compound having a bifunctional or higher functional ethylenically unsaturated group (b1). Polyfunctional unsaturated compound) (b2). Depending on the type, structure, molecular weight, etc. of the quaternary ammonium salt (A) having an unsaturated group and its oligomer and its polymer, only (b1) or (b2) is used as the compound (B) having an ethylenically unsaturated group. However, by using (b1) and (b2) in combination, the hardness and durability of the obtained cured product (dental filling material, artificial tooth shaped product, etc.) can be further improved.
前記単官能不飽和化合物(b1)は、分子内にエチレン性不飽和基1つを有するモノマーであれば、特に限定することはない。また、エチレン性不飽和基はラジカル重合性を有すれば特に限定されず、具体的には(メタ)アクリレート基、(メタ)アクリルアミド基、ビニル基、ビニルエーテル基、メチルビニルエーテル基、アリル基、(メタ)アリルエーテル基、マレイミド基等が挙げられる。(b1)の含有量は、光硬化型樹脂組成物全体に対して5〜99質量%であることが好ましい。また、10〜90質量%である場合、光硬化物の強度と硬度が良好であり、形成される歯冠、義歯などの表面平滑性、耐久性などが共に向上することができるためより好ましい。 The monofunctional unsaturated compound (b1) is not particularly limited as long as it is a monomer having one ethylenically unsaturated group in the molecule. The ethylenically unsaturated group is not particularly limited as long as it has radical polymerizable properties, and specifically, a (meth) acrylate group, a (meth) acrylamide group, a vinyl group, a vinyl ether group, a methyl vinyl ether group, an allyl group, ( Meta) Examples thereof include an allyl ether group and a maleimide group. The content of (b1) is preferably 5 to 99% by mass with respect to the entire photocurable resin composition. Further, when it is 10 to 90% by mass, the strength and hardness of the photocured product are good, and the surface smoothness and durability of the formed crown and denture can be improved, which is more preferable.
単官能性不飽和化合物(b1)のうち、(メタ)アクリレート基を含む化合物としては、例えば、(メタ)アクリル酸、炭素数が1〜22の直鎖、分岐、環状のアルキル基を導入したアルキル(メタ)アクリレート類、炭素数が1〜18の直鎖、分岐、環状のヒドロキシアルキル基を導入したヒドロキシアルキル(メタ)アクリレート類、(メタ)アクリル酸とヒドロキシアルキルカルボン酸類からなる(メタ)アクリル酸エチルカルボン酸、(メタ)アクリル酸エチルコハク酸、(メタ)アクリル酸エチルフタル酸、(メタ)アクリル酸エチルヘキサヒドロフタル酸等の(メタ)アクリル酸アルキルカルボン酸類、炭素数が1〜18の直鎖、分岐、環状のアルキルスルホン酸基を導入した(メタ)アクリル酸アルキルスルホン酸類、炭素数が1〜18の直鎖、分岐、環状のアルキルリン酸基を導入した(メタ)アクリル酸アルキルリン酸類、炭素数が1〜18のアルキル基と炭素数1〜4のアルキレングリコール基からなる官能基を導入したアルコキシアルキレングリコール(メタ)アクリレート類、アルコキシジアルキレングリコール(メタ)アクリレート類、アルコキシトリアルキレングリコール(メタ)アクリレート類、アルコキシポリアルキレングリコール(メタ)アクリレート類や、フェノキシ基と炭素数1〜4のアルキレングリコール基からなる官能基を導入したフェノキシアルキレングリコール(メタ)アクリレート類、フェノキシジアルキレングリコール(メタ)アクリレート類、フェノキシトリアルキレングリコール(メタ)アクリレート類、フェノキシポリアルキレングリコール(メタ)アクリレートや、炭素数が1〜6のアミノアルキル基を導入したN−アルキルアミノ(メタ)アクリレート類や、炭素数が1〜6のアミノアルキル基と炭素数1〜6のアルキル基からなるN−アルキルアミノアルキル基を導入したN−アルキルアミノアルキル(メタ)アクリレート類や、炭素数が1〜6のアミノアルキル基と炭素数1〜6のアルキル基からなるN,N−ジアルキルアミノアルキル基を導入したN,N−ジアルキルアミノアルキル(メタ)アクリレート類や、ベンジル(メタ)アクリレート、フェノキシエチル(メタ)アクリレート、ジシクロペンタニル(メタ)アクリレート、ジシクロペンタニルオキシエチル(メタ)アクリレート、ジシクロペンテニル(メタ)アクリレート、ジシクロペンテニルオキシエチル(メタ)アクリレート、ボルニル(メタ)アクリレート、イソボルニル(メタ)アクリレート、テトラヒドロフルフリル(メタ)アクリレート、2−メチル−2−アダマンチル(メタ)アクリレート等の環状構造を導入した(メタ)アクリレート類、グリシジル(メタ)アクリレート、4−ヒドロキシブチル(メタ)アクリレートグリシジルエーテル等のエポキシ基を導入した(メタ)アクリレート類が挙げられる。 Among the monofunctional unsaturated compounds (b1), as the compound containing a (meth) acrylate group, for example, (meth) acrylic acid, a linear, branched, or cyclic alkyl group having 1 to 22 carbon atoms was introduced. Alkyl (meth) acrylates, hydroxyalkyl (meth) acrylates with linear, branched, or cyclic hydroxyalkyl groups of 1 to 18 carbon atoms, (meth) acrylic acid and hydroxyalkylcarboxylic acids (meth). (Meta) alkylcarboxylic acids acrylates such as ethylcarboxylic acid acrylate, ethylsuccinic acid acrylate, ethylphthalic acid (meth) acrylate, ethylhexahydrophthalic acid acrylate, etc., having 1 to 18 carbon atoms. Alkyl sulfonic acids (meth) acrylates with linear, branched and cyclic alkylsulfonic acid groups, alkyl (meth) acrylates with linear, branched and cyclic alkylphosphate groups with 1-18 carbon atoms Phosphoric acids, alkoxyalkylene glycol (meth) acrylates introduced with a functional group consisting of an alkyl group having 1 to 18 carbon atoms and an alkylene glycol group having 1 to 4 carbon atoms, alkoxydialkylene glycol (meth) acrylates, alkoxytri Alkylene glycol (meth) acrylates, alkoxypolyalkylene glycol (meth) acrylates, phenoxyalkylene glycol (meth) acrylates introduced with a functional group consisting of a phenoxy group and an alkylene glycol group having 1 to 4 carbon atoms, phenoxydialkylene Glycol (meth) acrylates, phenoxytrialkylene glycol (meth) acrylates, phenoxypolyalkylene glycol (meth) acrylates, and N-alkylamino (meth) acrylates having an aminoalkyl group having 1 to 6 carbon atoms introduced therein. N-alkylaminoalkyl (meth) acrylates having an N-alkylaminoalkyl group composed of an aminoalkyl group having 1 to 6 carbon atoms and an alkyl group having 1 to 6 carbon atoms, and N-alkylaminoalkyl (meth) acrylates having 1 to 6 carbon atoms. N, N-dialkylaminoalkyl (meth) acrylates having an N, N-dialkylaminoalkyl group composed of an aminoalkyl group and an alkyl group having 1 to 6 carbon atoms, benzyl (meth) acrylate, and phenoxyethyl (meth) Aacrylate, dicyclopentanyl (meth) acrylate, dicyclopentanyloxyethyl (meth) acrylate, dicyclopentenyl (meth) acrylate, dicyclopente (Meta) acrylate introduced with a cyclic structure such as nyloxyethyl (meth) acrylate, Bornyl (meth) acrylate, isobornyl (meth) acrylate, tetrahydrofurfuryl (meth) acrylate, 2-methyl-2-adamantyl (meth) acrylate Examples include (meth) acrylates having an epoxy group introduced such as glycidyl (meth) acrylate and 4-hydroxybutyl (meth) acrylate glycidyl ether.
単官能性不飽和化合物(b1)のうち、(メタ)アクリルアミド基を含む化合物としては、(メタ)アクリルアミド、モノ又はジ置換(メタ)アクリルアミド、(メタ)アクロイルモルホリン、(メタ) ダイアセトンアクリルアミド等が挙げられ、また、モノ又はジ置換(メタ)アクリルアミドとしては、例えば、炭素数1から18の直鎖、分岐、環状のアルキル基を導入したN−アルキル(メタ)アクリルアミド、N,N−ジアルキル(メタ)アクリルアミド、炭素数が1〜6のヒドロキシアルキル基を導入したN−ヒロドキシアルキル(メタ)アクリルアミド、N,N−ジ(ヒロドキシアルキル)(メタ)アクリルアミド、N−ヒドロキシアルキル−N−(4−ヒドロキシフェニル)(メタ)アクリルアミド、炭素数が1〜6のヒドロキシアルキル基および炭素数1〜6のアルキル基を導入したN−アルキル−N−ヒロドキシアルキル(メタ)アクリルアミド、N−アルキル−N−(4−ヒドロキシフェニル)(メタ)アクリルアミドや、4−ヒドロキシフェニル(メタ)アクリルアミド、N,N−ジ(4−ヒドロキシフェニル)(メタ)アクリルアミド、炭素数が1〜6のアルコキシ基と炭素数1〜6のアルキレン基からなるアルコキシアルキル基を導入したN−アルコキシアルキル(メタ)アクリルアミド、N,N−ジ(アルコキシアルキル)(メタ)アクリルアミド、炭素数が1〜6のアルコキシ基と炭素数1〜6のアルキレン基からなるアルコキシアルキル基、炭素数が1〜6のアルキル基を導入したN−アルキル−N−アルコキシアルキル(メタ)アクリルアミド、炭素数が1〜6のアルキルスルホン酸基を導入したN−スルホアルキルアクリルアミド、炭素数が1〜6のアミノアルキル基を導入したN−アルキルアミノ(メタ)アクリルアミド、炭素数が1〜6のアミノアルキル基と炭素数1〜6のアルキル基からなるN−アルキルアミノアルキル基を導入したN−アルキルアミノアルキル(メタ)アクリルアミド、炭素数が1〜6のアミノアルキル基と炭素数1〜6のアルキル基からなるN,N−ジアルキルアミノアルキル基を導入したN,N−ジアルキルアミノアルキル(メタ)アクリルアミド等が挙げられる。 Among the monofunctional unsaturated compounds (b1), the compounds containing a (meth) acrylamide group include (meth) acrylamide, mono- or di-substituted (meth) acrylamide, (meth) acroylmorpholin, and (meth) diacetoneacrylamide. Examples of the mono- or di-substituted (meth) acrylamide include N-alkyl (meth) acrylamide having a linear, branched, or cyclic alkyl group having 1 to 18 carbon atoms introduced therein, N, N-. Dialkyl (meth) acrylamide, N-hirodoxyalkyl (meth) acrylamide introduced with hydroxyalkyl groups having 1 to 6 carbon atoms, N, N-di (hyrodoxyalkyl) (meth) acrylamide, N-hydroxyalkyl -N- (4-Hydroxyphenyl) (meth) acrylamide, N-alkyl-N-hirodoxyalkyl (meth) acrylamide introduced with hydroxyalkyl groups with 1 to 6 carbon atoms and alkyl groups with 1 to 6 carbon atoms. , N-alkyl-N- (4-hydroxyphenyl) (meth) acrylamide, 4-hydroxyphenyl (meth) acrylamide, N, N-di (4-hydroxyphenyl) (meth) acrylamide, carbon number 1-6 N-alkoxyalkyl (meth) acrylamide, N, N-di (alkoxyalkyl) (meth) acrylamide, which has an alkoxyalkyl group consisting of an alkoxy group and an alkylene group having 1 to 6 carbon atoms. An alkoxyalkyl group consisting of an alkoxy group and an alkylene group having 1 to 6 carbon atoms, N-alkyl-N-alkoxyalkyl (meth) acrylamide having an alkyl group having 1 to 6 carbon atoms introduced therein, and an alkyl having 1 to 6 carbon atoms. N-sulfoalkylacrylamide with sulfonic acid groups introduced, N-alkylamino (meth) acrylamide with aminoalkyl groups with 1 to 6 carbon atoms, aminoalkyl groups with 1 to 6 carbon atoms and 1 to 6 carbon atoms. N-alkylaminoalkyl (meth) acrylamide, which is an N-alkylaminoalkyl group composed of the above alkyl groups, N, N-dialkyl composed of an aminoalkyl group having 1 to 6 carbon atoms and an alkyl group having 1 to 6 carbon atoms. Examples thereof include N, N-dialkylaminoalkyl (meth) acrylamide introduced with an aminoalkyl group.
単官能性不飽和化合物(b1)のうち、ビニル基を含む化合物としては、炭素数が1〜22のカルボン酸を導入したカルボン酸ビニルエステル、炭素数が1〜22の直鎖、分岐、環状のアルキル基を導入したアルキルビニルエーテル、ビニルクロライド、N−ビニルピロリドン、N−ビニルカプロラクタム、N−ビニルオキサゾリン、マレイン酸、無水マレイン酸、フマル酸、イタコン酸、イタコン酸無水物、炭素数が1〜22の直鎖、分岐、環状のアルキル基を導入したマレイン酸モノアルキルエステル、マレイン酸ジアルキルエステル、マレイン酸モノアルキルアミド、マレイン酸ジアルキルアミド、マレイン酸アルキルイミド、フマル酸モノアルキルエステル、フマル酸ジアルキルエステル、フマル酸モノアルキルアミド、フマル酸ジアルキルアミド、イタコン酸モノアルキルエステル、イタコン酸ジアルキルエステル、イタコン酸モノアルキルアミド、イタコン酸ジアルキルアミド、イタコン酸アルキルイミド、ビニルカルボン酸、ビニルスルホン酸、ビニルリン酸等が挙げられる。 Among the monofunctional unsaturated compounds (b1), the compound containing a vinyl group includes a carboxylic acid vinyl ester introduced with a carboxylic acid having 1 to 22 carbon atoms, and a linear, branched, cyclic compound having 1 to 22 carbon atoms. Alkyl vinyl ether, vinyl chloride, N-vinylpyrrolidone, N-vinylcaprolactam, N-vinyloxazoline, maleic acid, maleic anhydride, fumaric acid, itaconic acid, itaconic acid anhydride, having 1 to 1 carbon atoms. Maleic acid monoalkyl ester introduced with 22 linear, branched and cyclic alkyl groups, maleic acid dialkyl ester, maleic acid monoalkylamide, maleic acid dialkylamide, maleic acid alkylimide, fumaric acid monoalkyl ester, fumaric acid dialkyl Esters, fumaric acid monoalkylamides, fumaric acid dialkylamides, itaconic acid monoalkyl esters, itaconic acid dialkyl esters, itaconic acid monoalkylamides, itaconic acid dialkylamides, itaconic acid alkylimides, vinylcarboxylic acids, vinylsulfonic acids, vinylphosphates. And so on.
単官能性不飽和化合物(b1)のうち、アリル基を含む化合物としては、炭素数が1〜22のカルボン酸を導入したカルボン酸アリルエステル、炭素数が1〜22の直鎖、分岐、環状のアルキル基を導入したアルキルアリルエーテル類、フェニルアリルエーテル、アルキルフェニルアリルエーテル、アリルアミン、分岐、環状のアルキル基を導入したモノまたはジアルキルアリルアミン等が挙げられる。 Among the monofunctional unsaturated compounds (b1), examples of the compound containing an allyl group include a carboxylic acid allyl ester introduced with a carboxylic acid having 1 to 22 carbon atoms, and a linear, branched, cyclic compound having 1 to 22 carbon atoms. Examples thereof include alkylallyl ethers introduced with the above alkyl group, phenylallyl ether, alkylphenylallyl ether, allylamine, branched mono- or dialkylallylamine introduced with a cyclic alkyl group.
単官能性不飽和化合物(b1)のうち、マレイミド基を含む化合物としては、炭素数が1〜22の直鎖、分岐、環状のアルキル基を導入したN−アルキルマレイミド、N−アルキル−α−メチルマレイミド、N−アルキル−α−エチルマレイミド、N−アルキル−α,β−ジメチルマレイミド、N−アルキル−α−フェニルマレイミド、炭素数が1〜12の直鎖、分岐、環状のヒドロキシアルキル基を導入したN−ヒドロキシアルキルマレイミド、N−ヒドロキシアルキル−α−メチルマレイミド、N−ヒドロキシアルキル−α−エチルマレイミド、N−ヒドロキシアルキル−α,β−ジメチルマレイミド、N−ヒドロキシアルキル−α−フェニルマレイミド、マレイミド基を有するアルコキシシラン化合物、マレイミド基を有するカルボン酸化合物等が挙げられる。 Among the monofunctional unsaturated compounds (b1), the maleimide group-containing compounds include N-alkylmaleimide and N-alkyl-α- having linear, branched, and cyclic alkyl groups having 1 to 22 carbon atoms introduced. Methylmaleimide, N-alkyl-α-ethylmaleimide, N-alkyl-α, β-dimethylmaleimide, N-alkyl-α-phenylmaleimide, linear, branched, cyclic hydroxyalkyl groups with 1-12 carbon atoms Introduced N-hydroxyalkylmaleimide, N-hydroxyalkyl-α-methylmaleimide, N-hydroxyalkyl-α-ethylmaleimide, N-hydroxyalkyl-α, β-dimethylmaleimide, N-hydroxyalkyl-α-phenylmaleimide, Examples thereof include an alkoxysilane compound having a maleimide group and a carboxylic acid compound having a maleimide group.
これらの単官能性不飽和化合物(b1)は1種類単独で使用してもよいし、また2種類以上併用してもよい。 These monofunctional unsaturated compounds (b1) may be used alone or in combination of two or more.
前記多官能性不飽和化合物(b2)としては、分子内にエチレン性不飽和基2つ以上を有するモノマーやオリゴマーであれば、特に限定することはない。また、エチレン性不飽和基はラジカル重合性を有すれば特に限定されず、具体的には(メタ)アクリレート基、(メタ)アクリルアミド基、ビニル基、ビニルエーテル基、メチルビニルエーテル基、アリル基、(メタ)アリルエーテル基、マレイミド基等が挙げられる。また、分子内にこれらのエチレン性不飽和基は、同一の官能基2つ以上を有するものもよいし、異なる官能基を任意に選べる2種以上を組み合わせたものでもよい。(b2)の含有量は、光硬化性型樹脂組成物全体に対して5〜99質量%であることが好ましい。また、(b2)の含有量は5〜80質量%である場合、調製される光硬化型樹脂組成物の粘度が調整しやすく、塗布性や充填性、歯の表面に対する密着性、接着性が共に満足でき、得られる光硬化物の強度に優れ、耐久性も十分のため、より好ましい。 The polyfunctional unsaturated compound (b2) is not particularly limited as long as it is a monomer or oligomer having two or more ethylenically unsaturated groups in the molecule. The ethylenically unsaturated group is not particularly limited as long as it has radical polymerizable properties, and specifically, a (meth) acrylate group, a (meth) acrylamide group, a vinyl group, a vinyl ether group, a methyl vinyl ether group, an allyl group, ( Meta) Examples thereof include an allyl ether group and a maleimide group. Further, these ethylenically unsaturated groups in the molecule may have two or more of the same functional groups, or may be a combination of two or more types in which different functional groups can be arbitrarily selected. The content of (b2) is preferably 5 to 99% by mass with respect to the entire photocurable resin composition. When the content of (b2) is 5 to 80% by mass, the viscosity of the prepared photocurable resin composition can be easily adjusted, and the coatability, filling property, adhesion to the tooth surface, and adhesiveness are improved. Both are satisfactory, the strength of the obtained photocured product is excellent, and the durability is sufficient, which is more preferable.
多官能性不飽和化合物(b2)のうち、例えば、(ジ)エチレングリコールジ(メタ)アクリレート、(トリ)プロピレングリコールジ(メタ)アクリレート、ジテトラエチレングリコールジ(メタ)アクリレート、ポリアルキレン(炭素数1〜4)グリコールジ(メタ)アクリレート、ポリテトラメチレングリコールジ(メタ)アクリレート、1,3(又は1,4)−ブタンジオールジ(メタ)アクリレート、1,6−ヘキサンジオールジ(メタ)アクリレート、シクロヘキサンジメタノールジ(メタ)アクリレート、アクリレートエステル(ジオキサングリコールジアクリレート)、アルコキシ化(シクロ)ヘキサンジオールジ(メタ)アクリレート、エポキシジ(メタ)アクリレート、ジシクロペンタニルジ(メタ)アクリレート、カプロラクトン変性ジシクロペンテニルジ(メタ)アクリレート、トリシクロデカンジメタノールジ(メタ)アクリレート、ポリエステルジ(メタ)アクリレート、エチレンオキサイド変性ビスフェノールAジ(メタ)アクリレート、プロピレンオキサイド変性ビスフェノールAジ(メタ)アクリレート、ポリウレタンジ(メタ)アクリレート、アリル(メタ)アクリレート、メチレンビス(メタ)アクリルアミド、エチレンビス(メタ)アクリルアミド、ポリウレタンジ(メタ)アクリルアミド、アリル(メタ)アクリルアミド、ペンタエリスリトールトリ(メタ)アクリレート、ペンタエリスリトールテトラ(メタ)アクリレート、トリメチロールエタントリ(メタ)アクリレート、トリメチロールプロパントリ(メタ)アクリレート、ジペンタエリスリトールトリ(メタ)アクリレート、ジトリメチロールプロパンテトラ(メタ)アクリレート、ジペンタエリスリトールテトラ(メタ)アクリレート、ジペンタエリスリトールペンタ(メタ)アクリレート、ジペンタエリスリトールヘキサ(メタ)アクリレート、トリ(メタ)アクリロイルオキシエトキシトリメチロールプロパン、グリセリンポリグリシジルエーテルポリ(メタ)アクリレート、イソシアヌル酸エチレンオキサイド変性トリ(メタ)アクリレート、エチレンオキサイド変性ジペンタエリスリトールペンタ(メタ)アクリレート、エチレンオキサイド変性ジペンタエリスリトールヘキサ(メタ)アクリレート、エチレンオキサイド変性ペンタエリスリトールトリ(メタ)アクリレート、エチレンオキサイド変性ペンタエリスリトールテトラ(メタ)アクリレート、コハク酸変性ペンタエリスリトールトリ(メタ)アクリレート等が挙げられる。これらの多官能性不飽和化合物(b2)は1種類単独で使用してもよいし、また2種類以上併用してもよい。 Among the polyfunctional unsaturated compounds (b2), for example, (di) ethylene glycol di (meth) acrylate, (tri) propylene glycol di (meth) acrylate, ditetraethylene glycol di (meth) acrylate, polyalkylene (carbon). Numbers 1 to 4) Glycoldi (meth) acrylate, polytetramethylene glycol di (meth) acrylate, 1,3 (or 1,4) -butanediol di (meth) acrylate, 1,6-hexanediol di (meth) Acrylate, cyclohexanedimethanol di (meth) acrylate, acrylate ester (dioxane glycol diacrylate), alkoxylated (cyclo) hexanediol di (meth) acrylate, epoxy di (meth) acrylate, dicyclopentanyldi (meth) acrylate, caprolactone Modified dicyclopentenyldi (meth) acrylate, tricyclodecanedimethanol di (meth) acrylate, polyester di (meth) acrylate, ethylene oxide-modified bisphenol A di (meth) acrylate, propylene oxide-modified bisphenol A di (meth) acrylate, Polyurethane di (meth) acrylate, allyl (meth) acrylate, methylenebis (meth) acrylamide, ethylenebis (meth) acrylamide, polyurethane di (meth) acrylamide, allyl (meth) acrylamide, pentaerythritol tri (meth) acrylate, pentaerythritol tetra (Meta) Acrylate, Trimethylol Ethantri (Meta) Acrylate, Trimethylol Propantri (Meta) Acrylate, Dipentaerythritol Tri (Meta) Acrylate, Ditrimethylol Propanetetra (Meta) Acrylate, Dipentaerythritol Tetra (Meta) Acrylate, Dipentaerythritol penta (meth) acrylate, dipentaerythritol hexa (meth) acrylate, tri (meth) acryloyloxyethoxytrimethylol propane, glycerin polyglycidyl ether poly (meth) acrylate, isocyanurate ethylene oxide-modified tri (meth) acrylate, Ethylene oxide-modified dipentaerythritol penta (meth) acrylate, ethylene oxide-modified dipentaerythritol hexa (meth) acrylate, ethylene oxide-modified pentaerythritol tri (meth) acrylate, ethylene oxide-modified pen Examples thereof include taerythritol tetra (meth) acrylate and succinic acid-modified pentaerythritol tri (meth) acrylate. These polyfunctional unsaturated compounds (b2) may be used alone or in combination of two or more.
本発明に用いられるエチレン性不飽和基を有する化合物(B)において、皮膚刺激性や臭気など安全性の観点及び不飽和基を有する第四級アンモニウム塩(A)との相溶性の観点から単官能性不飽和化合物(b1)は、メタクリレート系モノマー、メタクリルアミド系モノマー及びアクリルアミド系モノマーが好ましく、また硬化性の観点からアクリルアミド系モノマーがより好ましい。更に、硬化時の発熱量を制御するため、アクリルアミド系モノマーとメタクリレート系モノマーを併用することが最も好ましい。 The compound (B) having an ethylenically unsaturated group used in the present invention is simply from the viewpoint of safety such as skin irritation and odor and compatibility with the quaternary ammonium salt (A) having an unsaturated group. The functionally unsaturated compound (b1) is preferably a methacrylate-based monomer, a methacrylamide-based monomer, or an acrylamide-based monomer, and more preferably an acrylamide-based monomer from the viewpoint of curability. Further, in order to control the amount of heat generated during curing, it is most preferable to use an acrylamide-based monomer and a methacrylate-based monomer in combination.
本発明の抗菌性歯科用樹脂組成物は、可視光線や紫外線照射により十分に硬化することができる。不飽和基を有する第四級アンモニウム塩(A)及び/又はエチレン性不飽和基を有する化合物(B)の不飽和基がマレイミド基、α置換マレイミド基とα,β置換マレイミド基、ビニルエーテル基、メチルビニルエーテル基、アリル基、(メタ)アリルエーテル基からなる群より選択される1種以上の官能基である場合、これらの不飽和基が光照射により活性ラジカルを生じるため、光硬化型樹脂組成物には光重合開始剤を含有させなくてもよい。 The antibacterial dental resin composition of the present invention can be sufficiently cured by irradiation with visible light or ultraviolet rays. The unsaturated group of the quaternary ammonium salt (A) having an unsaturated group and / or the compound (B) having an ethylenically unsaturated group is a maleimide group, an α-substituted maleimide group and an α, β-substituted maleimide group, a vinyl ether group, When one or more functional groups selected from the group consisting of a methyl vinyl ether group, an allyl group, and a (meth) allyl ether group, these unsaturated groups generate active radicals by light irradiation, so that the photocurable resin composition The product does not have to contain a photopolymerization initiator.
本発明の抗菌性歯科用樹脂組成物は、光重合開始剤(C)を含有することができる。光重合開始剤としては、例えば、カンファーキノン、ベンジル、α−ナフチル、アセトナフテン、ナフトキノン、1,4−フェナントレンキノン、3,4−フェナントレンキノン、9,10−フェナントレンキノンなどのα−ジケトン類、2,4−ジエチルチオキサントンなどのチオキサントン類、2−ベンジル−ジメチルアミノ−1−(4−モルフォリノフェニル)−ブタノン−1、2−ベンジル−ジエチルアミノ−1−(4−モルフォリノフェニル)−ブタノン−1、2−ベンジル−ジメチルアミノ−1−(4−モルフォリノフェニル)−プロパノン−1、2−ベンジル−ジエチルアミノ−1−(4−モルフォリノフェニル)−プロパノン−1、2−ベンジル−ジメチルアミノ−1−(4−モルフォリノフェニル)−ペンタノン−1、2−ベンジル−ジエチルアミノ−1−(4−モルフォリノフェニル)−ペンタノンなどのα−アミノアセトフェノン類、2,4,6−トリメチルベンゾイルジフェニルホスフィンオキシド、ビス(2,6−ジメトキシベンゾイル)−2,4,4−トリメチルペンチルホスフィンオキシドなどのアシルホスフィンオキシド誘導体が挙げられる。これらの光開始重合剤は1種類単独で使用してもよいし、また2種類以上併用してもよい。 The antibacterial dental resin composition of the present invention can contain a photopolymerization initiator (C). Examples of the photopolymerization initiator include α-diketones such as camphorquinone, benzyl, α-naphthyl, acetonaphthene, naphthoquinone, 1,4-phenanthrenquinone, 3,4-phenanthrenquinone, and 9,10-phenanthrenquinone. Thioxanthons such as 2,4-diethylthioxanthone, 2-benzyl-dimethylamino-1- (4-morpholinophenyl) -butanone-1, 2-benzyl-diethylamino-1- (4-morpholinophenyl) -butanone- 1,2-benzyl-Dimethylamino-1- (4-morpholinophenyl) -propanone-1,2-benzyl-diethylamino-1- (4-morpholinophenyl) -propanone-1,2-benzyl-dimethylamino- Α-Aminoacetophenones such as 1- (4-morpholinophenyl) -pentanone-1,2-benzyl-diethylamino-1- (4-morpholinophenyl) -pentanone, 2,4,6-trimethylbenzoyldiphenylphosphine oxide , Bis (2,6-dimethoxybenzoyl) -2,4,4-trimethylpentylphosphine oxide and other acylphosphine oxide derivatives. One of these photoinitiator polymerization agents may be used alone, or two or more of them may be used in combination.
光重合開始剤(C)の含有量は、光硬化型歯科用樹脂組成物全体に対して0.1〜10質量%が好ましい。0.1質量%以上である場合には、薄塗りでも十分な硬化性を有し、得られる硬化膜の強度も耐久性も良好である。10質量%以下である場合、光硬化型樹脂組成物のポットライフが十分に長く、保管中のゲル化などのトラブルが発生しないものである。さらに、0.5〜5質量%がより好ましい。 The content of the photopolymerization initiator (C) is preferably 0.1 to 10% by mass with respect to the entire photocurable dental resin composition. When it is 0.1% by mass or more, it has sufficient curability even with a thin coating, and the strength and durability of the obtained cured film are good. When it is 10% by mass or less, the pot life of the photocurable resin composition is sufficiently long, and troubles such as gelation during storage do not occur. Further, 0.5 to 5% by mass is more preferable.
また、光重合開始剤の助剤として重合促進剤を配合することができる。例えば、N,N−ジメチルアニリン、N,N−ジエチルアニリン、N,N−ジ−n−ブチルアニリン、N,N−ジベンジルアニリン、N,N−ジメチル−p−トルイジン、N,N−ジエチル−p−トルイジン、N,N−ジメチル−m−トルイジン、p−ブロモ−N,N−ジメチルアニリン、m−クロロ−N,N−ジメチルアニリン、p−ジメチルアミノベンズアルデヒド、p−ジメチルアミノアセトフェノン、p−ジメチルアミノ安息香酸、p−ジメチルアミノ安息香酸メチル、p−ジメチルアミノ安息香酸エチル、p−ジメチルアミノ安息香酸アミル、N,N−ジメチルアンスラニックアシッドメチルエステル、N,N−ジヒドロキシエチルアニリン、N,N−ジヒドロキシエチル−p−トルイジン、p−ジメチルアミノフェネチルアルコール、p−ジメチルアミノスチルベン、N,N−ジメチル−3,5−キシリジン、4−ジメチルアミノピリジン、N,N−ジメチル−α−ナフチルアミン、N,N−ジメチル−β−ナフチルアミン、トリブチルアミン、トリプロピルアミン、トリエチルアミン、N−メチルジエタノールアミン、N−エチルジエタノールアミン、N,N−ジメチルヘキシルアミン、N,N−ジメチルドデシルアミン、N,N−ジメチルステアリルアミン、N,N−ジメチルアミノエチルアクリレート、N,N−ジメチルアミノエチルメタクリレート、2,2’−(n−ブチルイミノ)ジエタノールなどの第三級アミン類、5−ブチルバルビツール酸、1−ベンジル−5−フェニルバルビツール酸などのバルビツール酸類、ドデシルメルカプタン、ペンタエリスリトールテトラキス(チオグリコレート)等のメルカプト化合物が挙げられる。これらの重合促進剤は1種類単独で使用してもよいし、また2種類以上併用してもよい。 In addition, a polymerization accelerator can be blended as an auxiliary agent for the photopolymerization initiator. For example, N, N-dimethylaniline, N, N-diethylaniline, N, N-di-n-butylaniline, N, N-dibenzylaniline, N, N-dimethyl-p-toluidine, N, N-diethyl. -P-toluidine, N, N-dimethyl-m-toluidine, p-bromo-N, N-dimethylaniline, m-chloro-N, N-dimethylaniline, p-dimethylaminobenzaldehyde, p-dimethylaminoacetophenone, p -Dimethylaminobenzoic acid, methyl p-dimethylaminobenzoate, ethyl p-dimethylaminobenzoate, amyl p-dimethylaminobenzoate, N, N-dimethylanthranic acid methyl ester, N, N-dihydroxyethylaniline, N , N-dihydroxyethyl-p-toluidine, p-dimethylaminophenethyl alcohol, p-dimethylaminostylben, N, N-dimethyl-3,5-xylidine, 4-dimethylaminopyridine, N, N-dimethyl-α-naphthylamine , N, N-dimethyl-β-naphthylamine, tributylamine, tripropylamine, triethylamine, N-methyldiethanolamine, N-ethyldiethanolamine, N, N-dimethylhexylamine, N, N-dimethyldodecylamine, N, N- Tertiary amines such as dimethylstearylamine, N, N-dimethylaminoethyl acrylate, N, N-dimethylaminoethyl methacrylate, 2,2'-(n-butylimino) diethanol, 5-butylbarbituric acid, 1- Examples thereof include barbituric acids such as benzyl-5-phenylbarbituric acid, and mercapto compounds such as dodecyl mercaptan and pentaerythritol tetrakis (thioglycolate). These polymerization accelerators may be used alone or in combination of two or more.
前記の重合促進剤の含有量は、光硬化型歯科用樹脂組成物の全体に対して0.01〜2質量%が好ましい。この範囲内であれば、十分な重合促進剤効果を有し、かつ重合促進剤による着色や耐変色性低下などのトラブルが生じ難いものである。さらに、0.05〜1重量%がより好ましい。 The content of the polymerization accelerator is preferably 0.01 to 2% by mass with respect to the entire photocurable dental resin composition. Within this range, it has a sufficient effect of a polymerization accelerator, and troubles such as coloring and deterioration of discoloration resistance due to the polymerization accelerator are unlikely to occur. Further, 0.05 to 1% by weight is more preferable.
本発明の光硬化型歯科用樹脂組成物は、溶剤を含有しないまま用いることができる。また、より高精度な形状、光沢、硬度、表面平滑性などが要求される特殊品を得るため、必要に応じて、水や有機溶媒を含有してもよい。有機溶媒としては、常圧における沸点が50〜120℃であることが好ましく、また、沸点が55〜100℃であることがより好ましい。さらに、安全性の観点から、通常のマニキュア、エナメルなどに用いられる溶剤として水やアセトン、酢酸エチル、酢酸ブチル、エタノール、イソプロパノール等が特に好ましい。これらの溶剤は、1種単独でも、2種以上含有してもよい。溶剤を含有する場合の含有量は、光硬化型樹脂組成物全体に対して、1.0〜50質量%であることが好ましく、5〜30質量%であることがより好ましい。この範囲内であれば、光硬化型樹脂組成物を製造しやすく、且つ、硬化物の機械特性には悪影響を与える恐れがない。 The photocurable dental resin composition of the present invention can be used without containing a solvent. Further, in order to obtain a special product that requires more accurate shape, gloss, hardness, surface smoothness, etc., water or an organic solvent may be contained, if necessary. The organic solvent preferably has a boiling point of 50 to 120 ° C. at normal pressure, and more preferably 55 to 100 ° C. Further, from the viewpoint of safety, water, acetone, ethyl acetate, butyl acetate, ethanol, isopropanol and the like are particularly preferable as the solvent used for ordinary nail polish, enamel and the like. These solvents may be used alone or in combination of two or more. When the solvent is contained, the content is preferably 1.0 to 50% by mass, more preferably 5 to 30% by mass, based on the entire photocurable resin composition. Within this range, the photocurable resin composition can be easily produced, and the mechanical properties of the cured product may not be adversely affected.
本発明の抗菌性歯科用樹脂組成物(非光硬化型と光硬化型を含む)には、必要に応じて、各種の添加剤を配合することができる。具体的には、添加剤としては、熱重合禁止剤、酸化防止剤、紫外線増感剤、防腐剤、リン酸エステル系およびその他の難燃剤、界面活性剤、帯電防止剤、顔料、染料などの着色剤、香料、消泡剤、充填剤、シランカップロング剤、表面張力調整剤、可塑剤、表面潤滑剤、レベリング剤、軟化剤、有機フィラー、無機フィラー等を添加することができる。これらその他成分の添加量は、本発明による抗菌性歯科用樹脂組成物が発現する特性に悪影響を与えない程度であれば特に限定されず、樹脂組成物全体に対して5質量%以下の範囲が好ましい。但し、フィラーは樹脂の硬化物の強度と耐摩耗性を向上させる効果を有し、かつ、樹脂組成物を歯に塗布や充填する際に流動性を調整する作用を有するため、樹脂組成物全体に対して50質量%以下の範囲が好ましい。 Various additives can be added to the antibacterial dental resin composition (including non-photocurable type and photocurable type) of the present invention, if necessary. Specifically, the additives include thermal polymerization inhibitors, antioxidants, ultraviolet sensitizers, preservatives, phosphate ester-based and other flame retardants, surfactants, antistatic agents, pigments, dyes and the like. Colorants, fragrances, defoamers, fillers, silane cup long agents, surface tension modifiers, plasticizers, surface lubricants, leveling agents, softeners, organic fillers, inorganic fillers and the like can be added. The amount of these other components added is not particularly limited as long as it does not adversely affect the characteristics developed by the antibacterial dental resin composition according to the present invention, and is in the range of 5% by mass or less with respect to the entire resin composition. preferable. However, since the filler has the effect of improving the strength and abrasion resistance of the cured resin product and also has the effect of adjusting the fluidity when the resin composition is applied or filled on the teeth, the entire resin composition The range is preferably 50% by mass or less.
本発明の抗菌性歯科用樹脂組成物は、使用者の自歯、義歯や、義歯の床用材料、医療用器具を対象物として塗布、充填、造形などに用いることができる。具体的には、抗菌性樹脂組成物をこれらの対象物の表面に塗布し、乾燥により固化させ又は光照射により硬化させ、固化膜又は硬化膜として表面被覆材や表面被覆された器具が得られる。また、抗菌性樹脂組成物をこれらの対象物の補修部分に充填し、乾燥により固化させ又は光照射により硬化させ、固化物又は硬化物として接着剤や充填材料が得られる。さらに、立体造形による形成する場合、造形しながら乾燥、硬化により義歯、義歯用床材料、医療用器具などが得られる。本発明の抗菌性樹脂組成物は自歯に対しても、義歯の材料であるアクリル樹脂、セラミック、金属などに対しても優れる密着性、接着性を有するため、虫歯治療用レジン、歯冠材としても、審美治療用表面被覆材などとしても用いることができる。この場合、自歯の表面研磨、アルコール拭きなどの前処理を実施したら、耐久性がより向上されるが、前処理を実施しなくても、十分満足できる密着性、耐久性などが得られる。また、抗菌性樹脂組成物の固化膜又は硬化膜は強度と硬度、表面平滑性を併せ持つため、治療後の研磨等は特に不要である。本発明の抗菌性樹脂組成物は臭気も刺激性もなく、ブリードアウトしない成分から構成されているため、安全性が高く、歯の保護剤としても使用することができる。 The antibacterial dental resin composition of the present invention can be used for application, filling, modeling, etc. of a user's own teeth, dentures, denture floor materials, medical instruments, and the like. Specifically, the antibacterial resin composition is applied to the surface of these objects and solidified by drying or cured by light irradiation to obtain a surface coating material or a surface-coated instrument as a solidified film or a cured film. .. Further, the antibacterial resin composition is filled in the repaired portion of these objects and solidified by drying or cured by light irradiation to obtain an adhesive or a filling material as a solidified or cured product. Further, in the case of forming by three-dimensional modeling, dentures, denture floor materials, medical instruments and the like can be obtained by drying and hardening while modeling. Since the antibacterial resin composition of the present invention has excellent adhesion and adhesiveness to both natural teeth and acrylic resins, ceramics, metals and the like which are materials for dentures, it is a resin for treating dental caries and a crown material. However, it can also be used as a surface covering material for aesthetic treatment. In this case, if pretreatment such as surface polishing of the own tooth and wiping with alcohol is performed, the durability is further improved, but even if the pretreatment is not performed, sufficiently satisfactory adhesion and durability can be obtained. Further, since the solidified film or the cured film of the antibacterial resin composition has strength, hardness, and surface smoothness, polishing after treatment is not particularly necessary. Since the antibacterial resin composition of the present invention is composed of components that have neither odor nor irritation and do not bleed out, it is highly safe and can be used as a tooth protective agent.
本発明の抗菌性歯科用樹脂組成物は第四級アンモニウム塩を含有し、抗菌性に優れると共に防汚性が高い。また、汎用な顔料、光輝剤、染料などの有機系又は無機系のフィラーと均一に混ざりやすい。さらに、第四級アンモニウム塩のオリゴマーやポリマーは多種多様な構造、分子量などを要求物性に合わせて設計することが可能であり、歯科用接着剤、表面被覆材、充填材として、自歯や義歯などの表面に直接塗布、充填、補修することができる。厚膜の一層塗りでもよく、薄膜の積層塗りでもよい。さらに、適切な立体造形装置により立体造形物を形成することもできる。 The antibacterial dental resin composition of the present invention contains a quaternary ammonium salt and has excellent antibacterial properties and antifouling properties. In addition, it is easily mixed uniformly with organic or inorganic fillers such as general-purpose pigments, brighteners, and dyes. Furthermore, quaternary ammonium salt oligomers and polymers can be designed with a wide variety of structures and molecular weights according to the required physical properties, and can be used as dental adhesives, surface coating materials, and fillers for dentures and dentures. It can be applied, filled, and repaired directly on the surface. It may be a single layer coating of a thick film or a laminated coating of a thin film. Furthermore, a three-dimensional model can be formed by an appropriate three-dimensional model.
前記の無機系フィラーとしては、シリカ、カオリン、クレー、雲母、マイカ、結晶石英、ヒドロキシアパタイト、アルミナ、酸化チタン、酸化イットリウム、ジルコニア、リン酸カルシウム、硫酸バリウム、水酸化アルミニウム、フッ化ナトリウム、フッ化カリウム、モノフルオロリン酸ナトリウム、フッ化リチウム、フッ化カルシウム、フッ化イッテルビウム、フッ化イットリウムなどが挙げられる。また、長期間における安全性維持の観点で、シリカ、カオリン、クレー、雲母、マイカ、結晶石英、ヒドロキシアパタイト、アルミナ、酸化チタンが好ましい。これらの無機系フィラーは1種類単独で使用してもよいし、また2種類以上併用してもよい。 Examples of the inorganic filler include silica, kaolin, clay, mica, mica, crystalline quartz, hydroxyapatite, alumina, titanium oxide, yttrium oxide, zirconia, calcium phosphate, barium sulfate, aluminum hydroxide, sodium fluoride, and potassium fluoride. , Sodium monofluorophosphate, lithium fluoride, calcium fluoride, itterbium fluoride, yttrium fluoride and the like. Further, from the viewpoint of maintaining safety over a long period of time, silica, kaolin, clay, mica, mica, crystalline quartz, hydroxyapatite, alumina and titanium oxide are preferable. One type of these inorganic fillers may be used alone, or two or more types may be used in combination.
前記の有機系フィラーとしては、ポリメチルメタクリレート、ポリエチルメタクリレート、ポリメチルメタクリレートとポリエチルメタクリレートの共重合体、多官能メタクリレートの重合体、エチレン−酢酸ビニル共重合体、アクリロニトリル−ブタジエン−スチレン共重合体、ポリアミド、ポリスチレン、ポリ塩化ビニル、クロロプレンゴム、ニトリルゴム、スチレン−ブタジエンゴムが挙げられる。また、本発明に用いられる不飽和基を有する第四級アンモニウム塩のオリゴマー、ポリマーも有機系フィラーとして好適に用いることができる。これらの有機系フィラーは1種類単独で使用してもよいし、また2種類以上併用してもよい。 Examples of the organic filler include polymethylmethacrylate, polyethylmethacrylate, a polymer of polymethylmethacrylate and polyethylmethacrylate, a polymer of polyfunctional methacrylate, an ethylene-vinyl acetate copolymer, and an acrylonitrile-butadiene-styrene copolymer. Examples thereof include coalescence, polyamide, polystyrene, polyvinyl chloride, chloroprene rubber, nitrile rubber, and styrene-butadiene rubber. Further, the oligomer and polymer of the quaternary ammonium salt having an unsaturated group used in the present invention can also be preferably used as the organic filler. One type of these organic fillers may be used alone, or two or more types may be used in combination.
本発明の光硬化型歯科用樹脂組成物の光硬化に用いられる光源としては、特に制限することはなく、汎用な歯科用光照射器を用いることができる。例えば、公知の光源として、太陽光、蛍光灯、高圧水銀灯、メタルハライドランプ、紫外線(UV)ランプ、発光ダイオート(LED)ランプ、紫外線発光ダイオート(UV−LED)ランプ、紫外線レーザーダイオート(UV−LD)ランプなどが挙げられる。また、小型、長寿命、高効率、低コストと安全性の観点から、365nmの蛍光管を用いる紫外線照射タイプと405nmのLED光源を持つ可視光照射タイプが主流となりつつあり、これらを用いることがより好ましい The light source used for photocuring the photocurable dental resin composition of the present invention is not particularly limited, and a general-purpose dental light irradiator can be used. For example, known light sources include sunlight, fluorescent lamps, high-pressure mercury lamps, metal halide lamps, ultraviolet (UV) lamps, light emitting die auto (LED) lamps, ultraviolet light emitting die auto (UV-LED) lamps, and ultraviolet laser die auto (UV-LD). ) Lamps and the like. Further, from the viewpoint of small size, long life, high efficiency, low cost and safety, an ultraviolet irradiation type using a 365 nm fluorescent tube and a visible light irradiation type having a 405 nm LED light source are becoming mainstream, and these can be used. More preferred
本発明の光硬化型歯科用樹脂組成物の光硬化に必要な照射エネルギーは、用途や光源によって多少異なるが、照射エネルギー(積算光量)は1〜1000mJ/cm2の範囲が好ましく、10〜500mJ/cm2がより好ましい。この範囲であれば、樹脂組成物が十分に硬化でき、かつ、硬化物の硬度も強度も十分に満足できるためである。また、具体的な照射条件は歯の表面被覆や充填による補修、或いは立体造形装置による義歯の形成によって適宜に調整すればよい。例えば、UV照射による義歯用床材料向けの樹脂組成物を硬化させる場合、光源として市販の歯科用UVランプ(トクソーパワーライト、トクヤマデンタル社製)を用いて、1〜100秒間を照射すること、また、可視光線による自歯を補修される場合、光源として市販の歯科用照射器(ラボライトLV−II)を用いて、0.1〜2分間を照射することが特に好ましい。 The irradiation energy required for photocuring of the photocurable dental resin composition of the present invention varies slightly depending on the application and the light source, but the irradiation energy (integrated light amount) is preferably in the range of 1 to 1000 mJ / cm 2 , preferably 10 to 500 mJ. / Cm 2 is more preferred. This is because the resin composition can be sufficiently cured within this range, and the hardness and strength of the cured product can be sufficiently satisfied. Further, the specific irradiation conditions may be appropriately adjusted by repairing by covering or filling the tooth surface, or by forming a denture by a three-dimensional modeling device. For example, when curing a resin composition for a denture floor material by UV irradiation, a commercially available dental UV lamp (Tokuso Power Light, manufactured by Tokuyama Dental Co., Ltd.) is used as a light source and irradiated for 1 to 100 seconds. Further, when repairing a denture with visible light, it is particularly preferable to irradiate the tooth for 0.1 to 2 minutes using a commercially available dental irradiator (Laborite LV-II) as a light source.
以下、実施例及び比較例を挙げて本発明を更に具体的に説明するが、本発明はこれらの実施例に限定されるものではない。また、以下において「部」及び「%」は特記しない限りすべて質量基準である。 Hereinafter, the present invention will be described in more detail with reference to Examples and Comparative Examples, but the present invention is not limited to these Examples. In the following, "parts" and "%" are all based on mass unless otherwise specified.
不飽和基を有する第四級アンモニウム塩とそのオリゴマー及びポリマー(A−1)〜(A−10)を表1に示す。 Table 1 shows a quaternary ammonium salt having an unsaturated group and its oligomers and polymers (A-1) to (A-10).
実施例及び比較例に用いられる単官能性不飽和化合物(b1)は、以下に示す。
b1−1:イソボルニルアクリレート(IBOA)
b1−2:2−ヒドロキシエチルメタクリレート(HEMA)
b1−3:N−(2−ヒドロキシエチル)マレイミド(HEMI)
b1−4:メチルメタクリレート(MMA)
b1−5:4−ヒドロキシブチルアクリレート(4HBA)
b1−6:エトキシジエチレングリコールアクリレート(ECA)
b1−7:2‐ヒドロキシエチルビニルエーテル(HEVE)
b1−8:アクリロイルモルフォリン(KJケミカルズ株式会社の登録商標「ACMO」)
b1−9:ジメチルアクリルアミド(KJケミカルズ株式会社の登録商標「DMAA」)
b1−10:ジエチルアクリルアミド(KJケミカルズ株式会社の登録商標「DEAA」)
b1−11:N−(2−ヒドロキシエチル)アクリルアミド(KJケミカルズ株式会社の登録商標「HEAA」)
b1−12:イソプロピルアクリルアミド(KJケミカルズ株式会社の登録商標「NIPAM」)
b1−13:ジメチルアミノプロピルアクリルアミド(KJケミカルズ株式会社の登録商標「DMAPAA」)
b1−14:ダイアセトンアクリルアミド(KJケミカルズ株式会社の登録商標「Kohshylmer」DAAM)
b1−15:4−t−ブチルシクロヘキシルアクリレート((KJケミカルズ株式会社の登録商標「Kohshylmer」TBCHA)
b1−16:N−ビニルピロリドン(NVP)
b1−17:N−ビニルカプロラクタム(NVC)
The monofunctional unsaturated compound (b1) used in Examples and Comparative Examples is shown below.
b1-1: Isobornyl acrylate (IBOA)
b1-2: 2-Hydroxyethyl methacrylate (HEMA)
b1-3: N- (2-hydroxyethyl) maleimide (HEMI)
b1-4: Methyl methacrylate (MMA)
b1-5: 4-Hydroxybutyl acrylate (4HBA)
b1-6: ethoxydiethylene glycol acrylate (ECA)
b1-7: 2-Hydroxyethyl vinyl ether (HEVE)
b1-8: Acryloylmorpholin (registered trademark "ACMO" of KJ Chemicals Co., Ltd.)
b1-9: Dimethylacrylamide (registered trademark "DMAA" of KJ Chemicals Co., Ltd.)
b1-10: Diethylacrylamide (registered trademark "DEAA" of KJ Chemicals Co., Ltd.)
b1-11: N- (2-Hydroxyethyl) acrylamide (registered trademark "HEAA" of KJ Chemicals Co., Ltd.)
b1-12: Isopropylacrylamide (registered trademark "NIPAM" of KJ Chemicals Co., Ltd.)
b1-13: Dimethylaminopropylacrylamide (registered trademark "DMAPAA" of KJ Chemicals Co., Ltd.)
b1-14: Diacetone Acrylamide (registered trademark "Kohsylmer" DAAM of KJ Chemicals Co., Ltd.)
b1-15: 4-t-Butylcyclohexyl acrylate ((registered trademark "Kohsylmer" TBCHA of KJ Chemicals Co., Ltd.))
b1-16: N-vinylpyrrolidone (NVP)
b1-17: N-vinylcaprolactam (NVC)
実施例及び比較例に用いられる多官能性不飽和化合物(b2)は、以下に示す。
b2−1:トリエチレングリコールジアクリレート(TEGDA)
b2−2:ジペンタエリスリトールヘキサアクリレート(DPHA)
b2−3:トリメチロールプロハントリアクリレート(TMPTA)
b2−4:トリシクロデカンジメタノールジアクリレート(A−DCP、新中村化学工業株式会社製)
b2−5:ウレタンジアクリレート(UA、二官能、ポリエステル骨格、分子量5000)
b2−6:ウレタンジアクリルアミド(UAm、二官能、ポリカーボネート骨格、分子量8000)
The polyfunctional unsaturated compound (b2) used in Examples and Comparative Examples is shown below.
b2-1: Triethylene glycol diacrylate (TEGDA)
b2-2: Dipentaerythritol hexaacrylate (DPHA)
b2-3: Trimethylolpropane triacrylate (TMPTA)
b2-4: Tricyclodecanedimethanol diacrylate (A-DCP, manufactured by Shin-Nakamura Chemical Industry Co., Ltd.)
b2-5: Urethane diacrylate (UA, bifunctional, polyester skeleton, molecular weight 5000)
b2-6: Urethane diacrylamide (UAm, bifunctional, polycarbonate skeleton, molecular weight 8000)
実施例及び比較例に用いられる光重合開始剤(C)は、以下に示す。
C−1:カンファーキノン(Aldilich社製)
C−2:2,4,6−トリメチルベンゾイル−ジフェニル−フォスフィンオキサイド(IRGACURE−TPO、BASFジャパン株式会社製)
C−3:1−ヒドロキシシクロヘキシルフェニルケトン/ベンゾフェノン=1/1混合物(IRGACURE−500、BASFジャパン株式会社製)
The photopolymerization initiator (C) used in Examples and Comparative Examples is shown below.
C-1: Camphorquinone (manufactured by Aldilich)
C-2: 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide (IRGACURE-TPO, manufactured by BASF Japan Ltd.)
C-3: 1-Hydroxycyclohexylphenylketone / benzophenone = 1/1 mixture (IRGACURE-500, manufactured by BASF Japan Ltd.)
実施例1 光硬化型抗菌性樹脂組成物(D−1)の調製
(A)としてアクリロイルアミノプロピルトリメチルアンモニウムp?トルエンスルホナート(A−1)0.1質量部、(B)として「ACMO」(b1−8)50.0質量部、「HEAA」(b1−11)1.9質量部、TEGDA(b2−1)20.0質量部、UAm(b2−6)25.0質量部、(C)としてカンファーキノン(C−1)3.0質量部をそれぞれ容器に加え、40℃で1時間攪拌することにより、均一透明な実施例1の光硬化型抗菌性樹脂組成物(D−1)を得た。
Example 1 Preparation of photocurable antibacterial resin composition (D-1) as (A) 0.1 part by mass of acryloylaminopropyltrimethylammonium p? Toluenesulfonate (A-1), as (B) "ACMO" (B1-8) 50.0 parts by mass, "HEAA" (b1-11) 1.9 parts by mass, TEGDA (b2-1) 20.0 parts by mass, UAm (b2-6) 25.0 parts by mass, ( 3.0 parts by mass of camphorquinone (C-1) as C) was added to each container, and the mixture was stirred at 40 ° C. for 1 hour to obtain a uniform and transparent photocurable antibacterial resin composition (D-1) of Example 1. ) Was obtained.
実施例2〜10 光硬化型抗菌性樹脂組成物(D−2)〜(D−10)の調製
表2に示す組成で、実施例1と同様の操作を行うことにより、実施例2〜10に相当する光硬化型抗菌性樹脂組成物(D−2)〜(D−10)を得た。
Examples 2 to 10 Preparation of photocurable antibacterial resin compositions (D-2) to (D-10) Examples 2 to 10 by performing the same operations as in Example 1 with the compositions shown in Table 2. Photocurable antibacterial resin compositions (D-2) to (D-10) corresponding to the above were obtained.
比較例1〜3 光硬化性樹脂組成物(E−1)〜(E−3)の調製
表2に示す組成で、実施例1と同様の操作を行うことにより、比較例1〜3に相当する光硬化性樹脂組成物(E−1)〜(E−3)を得た。
Comparative Examples 1 to 3 Preparation of Photocurable Resin Compositions (E-1) to (E-3) Corresponding to Comparative Examples 1 to 3 by performing the same operation as in Example 1 with the compositions shown in Table 2. The photocurable resin compositions (E-1) to (E-3) to be used were obtained.
実施例1〜10で得られた光硬化型抗菌性樹脂組成物および比較例1〜3で得られた光硬化性樹脂組成物を用いて、以下の方法により評価を実施し、結果を表3に示す。 Using the photocurable antibacterial resin compositions obtained in Examples 1 to 10 and the photocurable resin compositions obtained in Comparative Examples 1 to 3, evaluation was carried out by the following methods, and the results are shown in Table 3. Shown in.
実施例1〜10で得られた光硬化型抗菌性樹脂組成物および比較例1〜3で得られた光硬化性樹脂組成物を用いて、目視により溶解性または分散性(不溶性無機系フィラーや顔料などを配合する場合)を観察し、また、組成物の保存安定性を評価し、それらの結果を表3に示す。さらに、下記方法により光硬化性歯科用材料を作製し、樹脂組成物の光硬化性、得られた歯科用材料の表面平滑性、硬度、接着強度を評価し、結果を表3に示す。抗菌性と防汚性について、代表的な口腔内細菌であるミュータンス菌(Streptococcus mutans)とカンジダ菌(Candida albicans)を用いて試験を実施し、結果を表4に示す。
1.溶解性(分散性)
◎:得られた樹脂組成物は均一かつ透明なものであった。
〇:得られた樹脂組成物は均一であって、半透明なものであった。
△:得られた樹脂組成物は白濁し、均一性を判断し難いものであった。
×:得られた樹脂組成物は完全に混ざらないものであった。
2.保存安定性
実施例1〜10で得られた光硬化型歯科用樹脂組成物および比較例1〜3で得られた光硬化性樹脂組成物を遮光性スクリュー管に入れ、蓋を閉め、40℃で1ヶ月及び80℃で2週間の二条件で保管した。保管後の組成物の溶解または分散状態を確認し、保存安定性を評価した。
○:40℃で1ヶ月及び80℃で2週間の二条件は共に保管後の状態変化がなかった。
△:40℃で1ヶ月又は80℃で2週間の何れか一条件において保管後の状態変化が確認された。
×:40℃で1ヶ月及び80℃で2週間の二条件は共に保管後の状態変が確認された。
3.硬化性
実施例1〜10で得られた光硬化型歯科用樹脂組成物および比較例1〜3で得られた光硬化性樹脂組成物を用い、中心に直径6mmの孔を有するポリテトラフルオロエチレン製のモールド(20mm×20mm×10mm)に樹脂組成物を充填し、ポリプロピレンフィルムで圧接し、歯科用光照射器(トクソーパワーライト、トクヤマデンタル社製、光出力密度700mW/cm2、照射面における光強度640?650mW/cm2、光源はハロゲンランプ、照射口径8mm)をポリプロピレンフィルムに密着して30秒間照射し、ポリプロピレンフィルムを剥がして硬化体手で触って、べたつき、未硬化成分の有無を確認した。
◎:べたつきが全くない(完全硬化)。
○:若干のべたつきがあるが、表面に指の跡が残らない(ほぼ完全硬化、未硬化成分の拭き取りは不要である)。
△:べとつきがあり、表面に指の跡が残る(不完全硬化、未硬化成分の拭き取りが必要である)。
×:べとつきがひどく、表面に指が貼りつく(未硬化成分が多く残存し、硬化膜として使用できない)。
4.表面平滑性
前記硬化性評価で得られた硬化物の表面を目視にて観察し、平滑性や光沢性を確認した。
◎:表面が平滑で、光沢がある。
○:表面がほぼ平滑で、うっすらと曇りまたは僅かな凹凸が見られる。
△:表面が全体的に曇っており、凹凸や粒状なものが多少確認される。
×:表面が全体的に曇って、粒状なものに覆われている。
5.硬度
前記硬化性評価で得られた硬化体の表面をバフ研磨したものを用い、松沢精機製微小硬度計で10g、20秒荷重でヌープ硬度を測定した。なお、測定温度は23℃であった。
◎:ヌープ硬度は200KHN以上(永久歯エナメル質相当)。
○:ヌープ硬度は70KHN以上、200KHN未満(象牙質相当)。
△:ヌープ硬度は70KHN未満。
×:硬化しなかったため、測定はできなかった。
6.接着強度(象牙質接着力)
牛下額前歯を注水下で#1000の耐水研磨紙で研磨し、平坦な接着用象牙質面を削り出し、圧縮空気を10秒間吹き付けて乾燥させ、直径3mmの穴の空いたテープを貼り付け、被着面を設定した。その後、公知の方法(特開2010−208964に記載方法を参考)により、接着試験片を作成した。接着試験片は37℃水中に24時間浸漬後、インストロン万能試験機(クロスヘッドスピード速度2mm/min)で引張接着強度を測定し、実施例1〜10および比較例1〜3で調製した光硬化性樹脂組成物のエナメル質と象牙質への接着力とした。なお、引張接着強度の値は5個の試験片の平均値である。
◎:エナメル質と象牙質の接着強度は共に20Mpa以上。
○:エナメル質と象牙質の接着強度はいずれか一つだけ20Mpa以上。
△:エナメル質と象牙質の接着強度は共に7Mpa以上。
×:エナメル質と象牙質の接着強度はいずれも7Mpa未満。
7.抗菌性
実施例1〜10および比較例1〜3で調製した光硬化性樹脂組成物を離型フィルム上に固定した厚さ200μm、内部が40mm×60mmのスペーサーに流し込み、溶媒のある場合は、溶媒を完全に除去(80℃、1分)し、紫外線を照射(積算光量1000mJ/cm2)により硬化させた後、離型フィルムを剥離し、抗菌性試験用硬化膜を得た。内径90mmのガラス製のシャーレ内に寒天培地流し込み、ミュータンス菌またはカンジダ菌を接種した後、その上に硬化膜1枚を置き、蓋を閉じ、温度30±5℃、湿度85±5%RHの恒温恒湿機内に7日間培養した。菌類の発育状況を4段階により評価を実施した。
◎:菌の発育が全くみられない。
○:僅かに菌の発育がみられる。
△:少し菌の発育がみられる。
×:激しい菌の発育が見られる。
8.防汚性(プラーク付着抑制)
公知の方法(特開2015−214514に記載方法を参考)により、実施例1〜10および比較例1〜3で調製した光硬化性樹脂組成物を用いて、前記2種の細菌に対してプラーク付着抑制試験を行った。
◎:プラーク付着が全く見られなかった。
○:僅かなプラーク付着が見られた。
△:プラーク付着が少し見られた。
×:激しいラーク付着が見られる。
Using the photocurable antibacterial resin compositions obtained in Examples 1 to 10 and the photocurable resin compositions obtained in Comparative Examples 1 to 3, they are visually soluble or dispersible (insoluble inorganic fillers and the like. (When a pigment or the like is blended) is observed, and the storage stability of the composition is evaluated, and the results are shown in Table 3. Further, a photocurable dental material was prepared by the following method, the photocurability of the resin composition, the surface smoothness, hardness, and adhesive strength of the obtained dental material were evaluated, and the results are shown in Table 3. The antibacterial and antifouling properties were tested using Streptococcus mutans and Candida albicans, which are typical oral bacteria, and the results are shown in Table 4.
1. 1. Soluble (dispersible)
⊚: The obtained resin composition was uniform and transparent.
〇: The obtained resin composition was uniform and translucent.
Δ: The obtained resin composition became cloudy and it was difficult to judge the uniformity.
X: The obtained resin composition was not completely mixed.
2. 2. Storage stability The photocurable dental resin compositions obtained in Examples 1 to 10 and the photocurable resin compositions obtained in Comparative Examples 1 to 3 were placed in a light-shielding screw tube, the lid was closed, and the temperature was 40 ° C. It was stored under two conditions of 1 month and 2 weeks at 80 ° C. The dissolved or dispersed state of the composition after storage was confirmed, and the storage stability was evaluated.
◯: There was no change in state after storage under the two conditions of 40 ° C. for 1 month and 80 ° C. for 2 weeks.
Δ: A change of state after storage was confirmed under any one condition of 40 ° C. for 1 month or 80 ° C. for 2 weeks.
X: Under the two conditions of 40 ° C. for 1 month and 80 ° C. for 2 weeks, the state change after storage was confirmed.
3. 3. Curability Polytetrafluoroethylene having a pore with a diameter of 6 mm in the center using the photocurable dental resin compositions obtained in Examples 1 to 10 and the photocurable resin compositions obtained in Comparative Examples 1 to 3. A mold (20 mm x 20 mm x 10 mm) made of plastic is filled with a resin composition, pressure-welded with a polypropylene film, and a dental light irradiator (Tokuso Power Light, manufactured by Tokuyama Dental Co., Ltd., light output density 700 mW / cm 2 , irradiation surface. Light intensity 640 to 650 mW / cm 2 , light source is halogen lamp, irradiation diameter 8 mm) is closely attached to the polypropylene film and irradiated for 30 seconds, the polypropylene film is peeled off and the cured product is touched by hand, and there are no sticky or uncured components. It was confirmed.
⊚: No stickiness (complete curing).
◯: There is some stickiness, but no finger marks are left on the surface (almost completely cured, it is not necessary to wipe off uncured components).
Δ: Sticky, leaving finger marks on the surface (incompletely cured, uncured components need to be wiped off).
X: The stickiness is severe and the finger sticks to the surface (a large amount of uncured components remain and cannot be used as a cured film).
4. Surface smoothness The surface of the cured product obtained in the curability evaluation was visually observed to confirm the smoothness and glossiness.
⊚: The surface is smooth and glossy.
◯: The surface is almost smooth, and a slight cloudiness or slight unevenness is observed.
Δ: The surface is cloudy as a whole, and some irregularities and graininess are confirmed.
X: The surface is entirely cloudy and covered with granular material.
5. Hardness Using a buffed surface of the cured product obtained in the above curability evaluation, the Knoop hardness was measured with a micro-hardness meter manufactured by Matsuzawa Seiki under a load of 10 g for 20 seconds. The measured temperature was 23 ° C.
⊚: Knoop hardness is 200 KHN or more (equivalent to permanent tooth enamel).
◯: Knoop hardness is 70 KHN or more and less than 200 KHN (equivalent to dentin).
Δ: Noup hardness is less than 70 KHN.
X: Measurement was not possible because it did not cure.
6. Adhesive strength (dentin adhesive strength)
The anterior teeth of the cow's forehead are polished with # 1000 water-resistant abrasive paper under water injection, the flat adhesive dentin surface is carved out, compressed air is blown for 10 seconds to dry, and a tape with a hole with a diameter of 3 mm is attached. , The adherend surface was set. Then, an adhesion test piece was prepared by a known method (refer to the method described in JP-A-2010-208964). The adhesion test piece was immersed in water at 37 ° C. for 24 hours, and then the tensile adhesive strength was measured with an Instron universal tester (crosshead speed 2 mm / min), and the light prepared in Examples 1 to 10 and Comparative Examples 1 to 3 was used. The adhesive strength of the curable resin composition to enamel and dentin was used. The value of the tensile adhesive strength is an average value of five test pieces.
⊚: Adhesive strength of both enamel and dentin is 20 Mpa or more.
◯: Only one of the adhesive strengths of enamel and dentin is 20 Mpa or more.
Δ: Adhesive strength of both enamel and dentin is 7 Mpa or more.
X: The adhesive strength between enamel and dentin is less than 7 Mpa.
7. Antibacterial properties The photocurable resin compositions prepared in Examples 1 to 10 and Comparative Examples 1 to 3 were poured into a spacer having a thickness of 200 μm and an inside of 40 mm × 60 mm fixed on a release film, and when there was a solvent, The solvent was completely removed (80 ° C., 1 minute), and the film was cured by irradiation with ultraviolet rays (cumulative light amount 1000 mJ / cm2), and then the release film was peeled off to obtain a cured film for antibacterial test. After pouring an agar medium into a glass petri dish with an inner diameter of 90 mm and inoculating it with mutans bacteria or Candida bacteria, place a cured film on it, close the lid, temperature 30 ± 5 ° C, humidity 85 ± 5% RH. The cells were cultured in a constant temperature and humidity chamber for 7 days. The growth status of fungi was evaluated in four stages.
⊚: No bacterial growth is observed.
◯: Slight bacterial growth is observed.
Δ: Slight bacterial growth is observed.
×: Violent bacterial growth is observed.
8. Antifouling property (suppression of plaque adhesion)
Plaque against the above two types of bacteria using the photocurable resin compositions prepared in Examples 1 to 10 and Comparative Examples 1 to 3 by a known method (refer to the method described in JP-A-2015-214514). An adhesion suppression test was conducted.
⊚: No plaque adhesion was observed.
◯: Slight plaque adhesion was observed.
Δ: A little plaque adhesion was observed.
X: Severe larks adhered.
実施例と比較例の結果に示されたとおり、本発明の不飽和基を有する第四級アンモニウム塩(A)及び/又はそのオリゴマー、ポリマーを含有する場合のみ、抗菌性に優れ、かつ、防汚性、光硬化型の硬化性及び保存安定性が全て満足できる歯科用樹脂組成物を取得することができた。 As shown in the results of Examples and Comparative Examples, only when the quaternary ammonium salt (A) having an unsaturated group of the present invention and / or its oligomer or polymer is contained, the antibacterial property is excellent and the prevention is prevented. We were able to obtain a dental resin composition that was satisfactory in terms of stain resistance, photocurable curability, and storage stability.
以上説明してきたように、本発明の抗菌性歯科用重合性樹脂組成物は優れる抗菌性を有し、歯科治療用材料としても好適に用いることができる。また、防汚性、安全性、光硬化型の硬化性及び保存安定性が良好で、コーティングや薄塗りでも、充填や厚塗りでも十分な強度や硬度と接着強度を有し、審美治療用材料や義歯材料として好適に用いることができ、立体造形物及びこれらに被覆された医療用器具を取得することも可能である。 As described above, the antibacterial dental polymerizable resin composition of the present invention has excellent antibacterial properties and can be suitably used as a material for dental treatment. In addition, it has good antifouling properties, safety, photocurable curability and storage stability, and has sufficient strength, hardness and adhesive strength for coating, thin coating, filling and thick coating, and is a material for aesthetic treatment. It can be suitably used as a material for dentures and dentures, and it is also possible to obtain a three-dimensional model and a medical device coated on the three-dimensional object.
Claims (21)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019029921A JP7232460B2 (en) | 2019-02-21 | 2019-02-21 | Polymerizable dental resin composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019029921A JP7232460B2 (en) | 2019-02-21 | 2019-02-21 | Polymerizable dental resin composition |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2020132590A true JP2020132590A (en) | 2020-08-31 |
JP2020132590A5 JP2020132590A5 (en) | 2022-02-01 |
JP7232460B2 JP7232460B2 (en) | 2023-03-03 |
Family
ID=72277594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019029921A Active JP7232460B2 (en) | 2019-02-21 | 2019-02-21 | Polymerizable dental resin composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7232460B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114672053A (en) * | 2022-03-11 | 2022-06-28 | 山东大学 | Method for preparing anion exchange membrane based on ternary liquid crystal system |
WO2022209973A1 (en) * | 2021-03-31 | 2022-10-06 | 三井化学株式会社 | Composition for dental material, dental material, and antibacterial composition |
WO2023039933A1 (en) * | 2021-09-15 | 2023-03-23 | 齐鲁工业大学 | Cell migration-promoting antibacterial coating for dental implant and preparation method therefor |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04217905A (en) * | 1990-09-14 | 1992-08-07 | Terumo Corp | Dentinal bonding promoting compound, pretreating agent and bonding composition containing the same |
JPH04327513A (en) * | 1991-04-23 | 1992-11-17 | Terumo Corp | Compound capable of promoting dentin adhesion, pretreating agent and bonding composition containing the same |
JPH04360808A (en) * | 1991-06-05 | 1992-12-14 | Terumo Corp | Adhesive for dentin |
JP2002530308A (en) * | 1998-11-23 | 2002-09-17 | デンツプライ インターナショナル インコーポレーテッド | Self-etching adhesive primer composition and polymerizable surfactant |
JP2011012240A (en) * | 2009-06-05 | 2011-01-20 | Kohjin Co Ltd | Quaternary cationic antistatic agent, antistatic composition and molded product containing the same |
JP2011074216A (en) * | 2009-09-30 | 2011-04-14 | Kohjin Co Ltd | Antistatic agent composed of quarternary cationic vinyl monomer and antistatic composition |
JP2011153109A (en) * | 2010-01-28 | 2011-08-11 | Kohjin Co Ltd | Antistatic agent comprising unsaturated quaternary ammonium salt compound and antistatic composition |
JP2012046687A (en) * | 2010-08-30 | 2012-03-08 | Kohjin Co Ltd | Active energy ray-curable resin composition and coating agent |
JP2013001654A (en) * | 2011-06-14 | 2013-01-07 | Kohjin Co Ltd | Method for producing unsaturated quaternary ammonium salt compound, and antistatic agent and antistatic composition comprising the same |
JP2015180740A (en) * | 2010-05-18 | 2015-10-15 | スリーエム イノベイティブ プロパティズ カンパニー | Polymerizable ionic liquid comprising aromatic carboxylate anion |
-
2019
- 2019-02-21 JP JP2019029921A patent/JP7232460B2/en active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04217905A (en) * | 1990-09-14 | 1992-08-07 | Terumo Corp | Dentinal bonding promoting compound, pretreating agent and bonding composition containing the same |
JPH04327513A (en) * | 1991-04-23 | 1992-11-17 | Terumo Corp | Compound capable of promoting dentin adhesion, pretreating agent and bonding composition containing the same |
JPH04360808A (en) * | 1991-06-05 | 1992-12-14 | Terumo Corp | Adhesive for dentin |
JP2002530308A (en) * | 1998-11-23 | 2002-09-17 | デンツプライ インターナショナル インコーポレーテッド | Self-etching adhesive primer composition and polymerizable surfactant |
JP2011012240A (en) * | 2009-06-05 | 2011-01-20 | Kohjin Co Ltd | Quaternary cationic antistatic agent, antistatic composition and molded product containing the same |
JP2011074216A (en) * | 2009-09-30 | 2011-04-14 | Kohjin Co Ltd | Antistatic agent composed of quarternary cationic vinyl monomer and antistatic composition |
JP2011153109A (en) * | 2010-01-28 | 2011-08-11 | Kohjin Co Ltd | Antistatic agent comprising unsaturated quaternary ammonium salt compound and antistatic composition |
JP2015180740A (en) * | 2010-05-18 | 2015-10-15 | スリーエム イノベイティブ プロパティズ カンパニー | Polymerizable ionic liquid comprising aromatic carboxylate anion |
JP2012046687A (en) * | 2010-08-30 | 2012-03-08 | Kohjin Co Ltd | Active energy ray-curable resin composition and coating agent |
JP2013001654A (en) * | 2011-06-14 | 2013-01-07 | Kohjin Co Ltd | Method for producing unsaturated quaternary ammonium salt compound, and antistatic agent and antistatic composition comprising the same |
Non-Patent Citations (3)
Title |
---|
DENTAL MATERIALS, vol. 31, JPN6022054775, 2015, pages 992 - 1002, ISSN: 0004953422 * |
INT. J. MOL. SCI., vol. 17, 1033, JPN6022054773, 2016, pages 1 - 13, ISSN: 0004953421 * |
JOURNAL OF DENTISTRY, vol. 41, JPN6022054771, 2013, pages 881 - 891, ISSN: 0004953423 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022209973A1 (en) * | 2021-03-31 | 2022-10-06 | 三井化学株式会社 | Composition for dental material, dental material, and antibacterial composition |
WO2023039933A1 (en) * | 2021-09-15 | 2023-03-23 | 齐鲁工业大学 | Cell migration-promoting antibacterial coating for dental implant and preparation method therefor |
CN114672053A (en) * | 2022-03-11 | 2022-06-28 | 山东大学 | Method for preparing anion exchange membrane based on ternary liquid crystal system |
Also Published As
Publication number | Publication date |
---|---|
JP7232460B2 (en) | 2023-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8846011B2 (en) | Curable resin composition for covering a fingernail or artificial fingernail | |
JP7232460B2 (en) | Polymerizable dental resin composition | |
JP6389368B2 (en) | Artificial nail coating composition with improved removability | |
US20040185013A1 (en) | Dental whitening compositions and methods | |
WO2021132699A1 (en) | Energy ray-curable coating material for three-dimensional molding, energy ray-curable material kit for three-dimensional molding containing said same, three-dimensional molded product obtained using same, and method for producing same | |
JP2019085330A (en) | Photocurable nail cosmetics | |
JPWO2014157271A1 (en) | Artificial nail composition, artificial nail, method for forming artificial nail, method for removing artificial nail, and nail art kit | |
US20170266102A1 (en) | Gel polish composition | |
JP7297228B2 (en) | antibacterial nail cosmetics | |
US20230392041A1 (en) | Polymerizable composition for dental tooth and material 3d printing | |
JP7199693B2 (en) | Photo-curing nail cosmetic | |
JPH04154708A (en) | Aqueous photo-setting type adhesive composition | |
JP7105225B2 (en) | Gel nail cosmetic composition, method of use thereof, nail cosmetic composition and nail cosmetic resin | |
TW202328219A (en) | Active energy ray-curable compositions, ink compositions, nail cosmetic compositions, adhesive compositions, bonding compositions, sealant compositions, coating agent compositions, self-restorable paints, and dental compositions | |
JP6429307B2 (en) | Artificial nail coating composition | |
JP2017088560A (en) | Light-curing artificial nail composition | |
US11000469B1 (en) | Nail gel builder composition | |
US5925689A (en) | Adhesive coatings curable by light | |
JP7289498B2 (en) | nail polish composition | |
JP4931342B2 (en) | Denture base coating material | |
JP2017149668A (en) | Nail primer composition, artificial nail, method of forming artificial nail, and nail art kit | |
JP2018123057A (en) | Nail cosmetics, and nail art kit | |
JP7426218B2 (en) | UV curable resin composition | |
CN106176251A (en) | A kind of polyurethane dental prosthetic material and preparation and application thereof | |
JP2557564B2 (en) | Oxygen blocker |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220124 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220124 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221227 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230130 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230207 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230210 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230210 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7232460 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |